Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
ShockWave Medical initiates all-female coronary IVL study » 09:02
09/19/22
09/19
09:02
09/19/22
09:02
SWAV

ShockWave Medical

$285.52 /

+1.89 (+0.67%)

Shockwave Medical has…

Shockwave Medical has initiated the first-ever prospective coronary intervention study consisting of all female patients - EMPOWER CAD - to determine whether the positive results from earlier coronary IVL studies with the Shockwave C2 Coronary IVL Catheter, which showed similar safety outcomes across both sexes, can be replicated in an expanded, 'real-world' population of female patients with severely calcified coronary lesions. This prospective, multicenter registry will enroll up to 400 female patients with symptomatic ischemic heart disease in up to 50 investigational centers in the United States and Europe and will include a 3-year follow-up. EMPOWER CAD co-principal investigators Margaret McEntegart, MD, PhD, Director of Complex Percutaneous Coronary Intervention Program at Columbia University Medical Center/New York-Presbyterian Hospital and Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine, Section of Cardiovascular Medicine and Director, Heart and Vascular Clinical Research Program at Yale University School of Medicine, along with the study's European lead, Nieves Gonzalo, Consultant Interventional Cardiologist at Hospital Clinico San Carlos in Madrid, Spain, announced the study at the Transcatheter Cardiovascular Therapeutics annual scientific symposium of the Cardiovascular Research Foundation in Boston, Mass.

ShowHide Related Items >><<
SWAV ShockWave Medical
$285.52 /

+1.89 (+0.67%)

SWAV ShockWave Medical
$285.52 /

+1.89 (+0.67%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
SWAV ShockWave Medical
$285.52 /

+1.89 (+0.67%)

SWAV ShockWave Medical
$285.52 /

+1.89 (+0.67%)

SWAV ShockWave Medical
$285.52 /

+1.89 (+0.67%)

Conference/Events
Wells Fargo to hold a conference » 04:55
09/09/22
09/09
04:55
09/09/22
04:55
ABBV

AbbVie

$140.52 /

+1.48 (+1.06%)

, AVEO

Aveo Pharmaceuticals

$8.59 /

+0.28 (+3.37%)

, BNFT

Benefitfocus

$6.92 /

-0.13 (-1.84%)

, DGX

Quest Diagnostics

$130.17 /

+2.86 (+2.25%)

, FATE

Fate Therapeutics

$28.25 /

+0.935 (+3.42%)

, INSP

Inspire Medical

$197.41 /

+8.2 (+4.33%)

, LEGN

Legend Biotech

$43.61 /

-0.25 (-0.57%)

, GILD

Gilead

$65.11 /

+0.325 (+0.50%)

, HOLX

Hologic

$68.88 /

+1.17 (+1.73%)

, INGN

Inogen

$27.44 /

-0.75 (-2.66%)

, KYMR

Kymera Therapeutics

$28.76 /

+0.27 (+0.95%)

, NOTV

Inotiv

$21.74 /

+0.68 (+3.23%)

, PEN

Penumbra

$197.58 /

+11.9 (+6.41%)

, RGLS

Regulus

$1.61 /

+0.04 (+2.55%)

, SWAV

ShockWave Medical

$292.67 /

+4.85 (+1.69%)

, WAT

Waters

$308.63 /

+6.55 (+2.17%)

, SUPN

Supernus

$34.53 /

+0.34 (+0.99%)

, ORIC

Oric Pharmaceuticals

$3.56 /

+0.12 (+3.49%)

, PGEN

Precigen

$2.46 /

+0.145 (+6.28%)

, NRIX

Nurix Therapeutics

$15.99 /

-0.13 (-0.81%)

, NUVA

NuVasive

$46.21 /

+0.89 (+1.96%)

, AUTL

Autolus Therapeutics

$3.12 /

+0.19 (+6.48%)

, HALO

Halozyme

$39.63 /

+0.25 (+0.63%)

, IMVT

Immunovant

$5.06 /

+0.145 (+2.95%)

, JNCE

Jounce Therapeutics

$3.49 /

-0.06 (-1.69%)

, IDYA

Ideaya Biosciences

$9.31 /

+0.01 (+0.11%)

, SYK

Stryker

$220.34 /

+9.14 (+4.33%)

, NPCE

NeuroPace

$4.50 /

-0.275 (-5.77%)

, IONS

Ionis Pharmaceuticals

$44.28 /

+0.9 (+2.07%)

, HRMY

Harmony Biosciences

$47.66 /

+1.675 (+3.64%)

2022 Wells Fargo…

2022 Wells Fargo Healthcare Conference to be held in Everett, MA on September 7-9.

ShowHide Related Items >><<
SYK Stryker
$220.34 /

+9.14 (+4.33%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SUPN Supernus
$34.53 /

+0.34 (+0.99%)

RGLS Regulus
$1.61 /

+0.04 (+2.55%)

PGEN Precigen
$2.46 /

+0.145 (+6.28%)

ORIC Oric Pharmaceuticals
$3.56 /

+0.12 (+3.49%)

NUVA NuVasive
$46.21 /

+0.89 (+1.96%)

NRIX Nurix Therapeutics
$15.99 /

-0.13 (-0.81%)

NPCE NeuroPace
$4.50 /

-0.275 (-5.77%)

NOTV Inotiv
$21.74 /

+0.68 (+3.23%)

LEGN Legend Biotech
$43.61 /

-0.25 (-0.57%)

KYMR Kymera Therapeutics
$28.76 /

+0.27 (+0.95%)

JNCE Jounce Therapeutics
$3.49 /

-0.06 (-1.69%)

IONS Ionis Pharmaceuticals
$44.28 /

+0.9 (+2.07%)

INSP Inspire Medical
$197.41 /

+8.2 (+4.33%)

IMVT Immunovant
$5.06 /

+0.145 (+2.95%)

IDYA Ideaya Biosciences
$9.31 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$47.66 /

+1.675 (+3.64%)

HOLX Hologic
$68.88 /

+1.17 (+1.73%)

HALO Halozyme
$39.63 /

+0.25 (+0.63%)

GILD Gilead
$65.11 /

+0.325 (+0.50%)

FATE Fate Therapeutics
$28.25 /

+0.935 (+3.42%)

DGX Quest Diagnostics
$130.17 /

+2.86 (+2.25%)

BNFT Benefitfocus
$6.92 /

-0.13 (-1.84%)

AVEO Aveo Pharmaceuticals
$8.59 /

+0.28 (+3.37%)

AUTL Autolus Therapeutics
$3.12 /

+0.19 (+6.48%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

08/30/22 Piper Sandler
I-Mab price target lowered to $30 from $35 at Piper Sandler
08/24/22 Argus
AbbVie price target lowered to $155 from $165 at Argus
08/01/22 JPMorgan
AbbVie selloff Friday a buying opportunity, says JPMorgan
08/01/22 Barclays
AbbVie price target lowered to $160 from $174 at Barclays
AVEO Aveo Pharmaceuticals
$8.59 /

+0.28 (+3.37%)

03/14/22 JonesTrading
Aveo Pharmaceuticals initiated with a Buy at JonesTrading
BNFT Benefitfocus
$6.92 /

-0.13 (-1.84%)

09/06/22 Piper Sandler
Benefitfocus price target lowered to $6 from $9 at Piper Sandler
06/22/22 Piper Sandler
Benefitfocus downgraded to Neutral from Overweight at Piper Sandler
DGX Quest Diagnostics
$130.17 /

+2.86 (+2.25%)

08/22/22 Morgan Stanley
Quest Diagnostics assumed with an Equal Weight at Morgan Stanley
07/22/22 Mizuho
Quest Diagnostics price target lowered to $160 from $185 at Mizuho
07/22/22 Credit Suisse
Quest Diagnostics price target lowered to $143 from $158 at Credit Suisse
04/24/22 UBS
Quest Diagnostics price target raised to $150 from $139 at UBS
FATE Fate Therapeutics
$28.25 /

+0.935 (+3.42%)

08/18/22 Wells Fargo
Fate Therapeutics assumed with an Overweight at Wells Fargo
08/04/22 Oppenheimer
Fate Therapeutics price target lowered to $90 from $135 at Oppenheimer
07/28/22 Needham
Fate Therapeutics initiated with a Hold at Needham
07/11/22 BMO Capital
Fate Therapeutics upgraded to Outperform from Market Perform at BMO Capital
INSP Inspire Medical
$197.41 /

+8.2 (+4.33%)

08/03/22 Truist
Inspire Medical price target raised to $280 from $250 at Truist
08/03/22 Piper Sandler
Inspire Medical price target lowered to $285 from $310 at Piper Sandler
07/05/22 Piper Sandler
Piper says Inspire appears to have received FDA approval for expanded labeling
06/10/22 Truist
Inspire Medical price target lowered to $250 from $296 at Truist
LEGN Legend Biotech
$43.61 /

-0.25 (-0.57%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/16/22 BMO Capital
Legend Biotech initiated with an Outperform at BMO Capital
05/31/22 Morgan Stanley
Legend Biotech named Catalyst Driven Idea by Morgan Stanley
03/15/22 Barclays
Legend Biotech initiated with an Overweight at Barclays
GILD Gilead
$65.11 /

+0.325 (+0.50%)

09/02/22 Argus
Gilead pullback provides favorable entry point, says Argus
08/15/22 Piper Sandler
Gilead's Trodelvy shows OS benefit in HR+/HER- BC, says Piper Sandler
08/15/22 Piper Sandler
Gilead price target raised to $74 from $71 at Piper Sandler
08/08/22 Truist
Gilead price target lowered to $71 from $75 at Truist
HOLX Hologic
$68.88 /

+1.17 (+1.73%)

07/22/22 Evercore ISI
Intuitive Surgical price target lowered to $175 from $210 at Evercore ISI
07/20/22 UBS
Hologic initiated with a Neutral at UBS
07/20/22 BofA
BofA cuts Hologic to Neutral amid difficult macro, ongoing supply chain issues
07/20/22 BofA
Hologic downgraded to Neutral from Buy at BofA
INGN Inogen
$27.44 /

-0.75 (-2.66%)

05/09/22 Stifel
Inogen price target lowered to $30 from $40 at Stifel
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
KYMR Kymera Therapeutics
$28.76 /

+0.27 (+0.95%)

08/31/22 JPMorgan
Kymera selloff a 'misplaced knee-jerk reaction,' says JPMorgan
08/15/22 Jefferies
Kymera Therapeutics initiated with a Buy at Jefferies
08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
NOTV Inotiv
$21.74 /

+0.68 (+3.23%)

08/11/22 Lake Street
Inotiv price target raised to $60 from $50 at Lake Street
06/14/22 Lake Street
Inotiv price target lowered to $50 from $75 at Lake Street
02/11/22 Lake Street
Inotiv price target raised to $75 from $60 at Lake Street
02/02/22 Craig-Hallum
Inotiv price target raised to $64 from $57 at Craig-Hallum
PEN Penumbra
$197.58 /

+11.9 (+6.41%)

08/05/22 Canaccord
Penumbra price target lowered to $189 from $244 at Canaccord
07/21/22 Deutsche Bank
Penumbra price target lowered to $163 from $250 at Deutsche Bank
07/18/22 BTIG
Penumbra price target lowered to $213 from $272 at BTIG
07/18/22 RBC Capital
Penumbra initiated with an Outperform at RBC Capital
RGLS Regulus
$1.61 /

+0.04 (+2.55%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
WAT Waters
$308.63 /

+6.55 (+2.17%)

08/24/22 Credit Suisse
Waters initiated with a Neutral at Credit Suisse
08/03/22 Baird
Waters price target raised to $348 from $340 at Baird
07/20/22 UBS
Waters initiated with a Neutral at UBS
07/05/22 Evercore ISI
Waters added to 'Tactical Outperform' list at Evercore ISI
SUPN Supernus
$34.53 /

+0.34 (+0.99%)

08/31/22 Piper Sandler
Supernus price target raised to $38 from $33 at Piper Sandler
12/01/21 Jefferies
Supernus resumed with a Buy at Jefferies
10/12/21 JMP Securities
Adamas Pharmaceuticals cut to Market Perform from Outperform at JMP Securities
10/12/21 H.C. Wainwright
Adamas Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ORIC Oric Pharmaceuticals
$3.56 /

+0.12 (+3.49%)

07/15/22 Oppenheimer
Oric Pharmaceuticals assumed with a Perform at Oppenheimer
04/04/22 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/22 H.C. Wainwright
Oric Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/22/22 Guggenheim
Oric downgraded to Neutral at Guggenheim after ORIC-101 discontinuation
PGEN Precigen
$2.46 /

+0.145 (+6.28%)

08/09/22 H.C. Wainwright
Precigen price target lowered to $6 from $10 at H.C. Wainwright
07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
NRIX Nurix Therapeutics
$15.99 /

-0.13 (-0.81%)

07/11/22 H.C. Wainwright
Nurix Therapeutics price target lowered to $54 from $60 at H.C. Wainwright
07/08/22 Stifel
Nurix Therapeutics price target lowered to $37 from $44 at Stifel
07/08/22 JPMorgan
Nurix Therapeutics price target lowered to $37 from $46 at JPMorgan
07/08/22 Baird
Nurix Therapeutics price target lowered to $32 from $41 at Baird
NUVA NuVasive
$46.21 /

+0.89 (+1.96%)

08/23/22 Piper Sandler
NuVasive selloff on bus tour comments an opportunity, says Piper Sandler
08/04/22 Canaccord
NuVasive price target raised to $55 from $50 at Canaccord
08/04/22 Piper Sandler
NuVasive price target lowered to $60 from $80 at Piper Sandler
06/28/22 Stifel
Stifel cuts Orthofix target, says momentum 'faded' during Q2
AUTL Autolus Therapeutics
$3.12 /

+0.19 (+6.48%)

06/14/22 Truist
Autolus Therapeutics price target lowered to $11 from $13 at Truist
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
12/20/21 H.C. Wainwright
Autolus Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
HALO Halozyme
$39.63 /

+0.25 (+0.63%)

08/10/22 Benchmark
Halozyme recent weakness a buying opportunity, says Benchmark
05/23/22 SVB Securities
Halozyme initiated with an Outperform at SVB Leerink
04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
04/14/22 Raymond James
Antares Pharma downgraded to Market Perform from Strong Buy at Raymond James
IMVT Immunovant
$5.06 /

+0.145 (+2.95%)

03/30/22 Chardan
Immunovant price target lowered to $14 from $20 at Chardan
01/05/22 Chardan
Immunovant price target lowered to $20 from $22 at Chardan
12/31/21 Wells Fargo
Immunovant shares to remain range-bound in 2022, says Wells Fargo
12/08/21 Wells Fargo
Immunovant initiated with an Equal Weight at Wells Fargo
JNCE Jounce Therapeutics
$3.49 /

-0.06 (-1.69%)

08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
05/23/22 Piper Sandler
Jounce Therapeutics price target lowered to $9 from $17 at Piper Sandler
05/12/22 Roth Capital
Jounce Therapeutics recent pullback overdone, says Roth Capital
IDYA Ideaya Biosciences
$9.31 /

+0.01 (+0.11%)

08/16/22 Baird
Ideaya Biosciences price target lowered to $18 from $26 at Baird
08/16/22 Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold from Buy at Stifel
SYK Stryker
$220.34 /

+9.14 (+4.33%)

09/06/22 BTIG
Stryker price target lowered to $238 from $244 at BTIG
07/28/22 Edward Jones
Stryker upgraded to Buy at Edward Jones following pullback
07/28/22 Edward Jones
Stryker upgraded to Buy from Hold at Edward Jones
07/27/22 Wells Fargo
Stryker price target lowered to $237 from $286 at Wells Fargo
NPCE NeuroPace
$4.50 /

-0.275 (-5.77%)

04/05/22 Wolfe Research
NeuroPace initiated with an Outperform at Wolfe Research
01/19/22 Wells Fargo
Wells Fargo downgrades NeuroPace to Equal Weight, lowers price target to $11
01/19/22 Wells Fargo
NeuroPace downgraded to Equal Weight from Overweight at Wells Fargo
01/07/22 Morgan Stanley
NeuroPace cut to Underweight at Morgan Stanley on cloudy near-term outlook
IONS Ionis Pharmaceuticals
$44.28 /

+0.9 (+2.07%)

08/10/22 Citi
Ionis Pharmaceuticals price target raised to $28 from $26 at Citi
07/26/22 Piper Sandler
Ionis Pharmaceuticals price target raised to $58 from $55 at Piper Sandler
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
07/18/22 Oppenheimer
Ionis Pharmaceuticals assumed with an Outperform at Oppenheimer
HRMY Harmony Biosciences
$47.66 /

+1.675 (+3.64%)

09/01/22 Mizuho
Harmony Biosciences recent weakness a buying opportunity, says Mizuho
08/18/22 Mizuho
Harmony Biosciences Orange Book update 'incremental negative,' says Mizuho
08/03/22 Jefferies
Jefferies downgrades Harmony Biosciences to Hold, sees limited near-term upside
08/03/22 Oppenheimer
Harmony Biosciences price target raised to $67 from $62 at Oppenheimer
WAT Waters
$308.63 /

+6.55 (+2.17%)

SYK Stryker
$220.34 /

+9.14 (+4.33%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SUPN Supernus
$34.53 /

+0.34 (+0.99%)

RGLS Regulus
$1.61 /

+0.04 (+2.55%)

PGEN Precigen
$2.46 /

+0.145 (+6.28%)

PEN Penumbra
$197.58 /

+11.9 (+6.41%)

ORIC Oric Pharmaceuticals
$3.56 /

+0.12 (+3.49%)

NUVA NuVasive
$46.21 /

+0.89 (+1.96%)

NRIX Nurix Therapeutics
$15.99 /

-0.13 (-0.81%)

NPCE NeuroPace
$4.50 /

-0.275 (-5.77%)

LEGN Legend Biotech
$43.61 /

-0.25 (-0.57%)

KYMR Kymera Therapeutics
$28.76 /

+0.27 (+0.95%)

JNCE Jounce Therapeutics
$3.49 /

-0.06 (-1.69%)

IONS Ionis Pharmaceuticals
$44.28 /

+0.9 (+2.07%)

INSP Inspire Medical
$197.41 /

+8.2 (+4.33%)

INGN Inogen
$27.44 /

-0.75 (-2.66%)

IMVT Immunovant
$5.06 /

+0.145 (+2.95%)

IDYA Ideaya Biosciences
$9.31 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$47.66 /

+1.675 (+3.64%)

HOLX Hologic
$68.88 /

+1.17 (+1.73%)

HALO Halozyme
$39.63 /

+0.25 (+0.63%)

GILD Gilead
$65.11 /

+0.325 (+0.50%)

FATE Fate Therapeutics
$28.25 /

+0.935 (+3.42%)

DGX Quest Diagnostics
$130.17 /

+2.86 (+2.25%)

BNFT Benefitfocus
$6.92 /

-0.13 (-1.84%)

AVEO Aveo Pharmaceuticals
$8.59 /

+0.28 (+3.37%)

AUTL Autolus Therapeutics
$3.12 /

+0.19 (+6.48%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

  • 12
    Aug
  • 27
    Jul
  • 16
    Dec
SYK Stryker
$220.34 /

+9.14 (+4.33%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

GILD Gilead
$65.11 /

+0.325 (+0.50%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

SYK Stryker
$220.34 /

+9.14 (+4.33%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SUPN Supernus
$34.53 /

+0.34 (+0.99%)

PEN Penumbra
$197.58 /

+11.9 (+6.41%)

ORIC Oric Pharmaceuticals
$3.56 /

+0.12 (+3.49%)

NUVA NuVasive
$46.21 /

+0.89 (+1.96%)

NRIX Nurix Therapeutics
$15.99 /

-0.13 (-0.81%)

LEGN Legend Biotech
$43.61 /

-0.25 (-0.57%)

KYMR Kymera Therapeutics
$28.76 /

+0.27 (+0.95%)

JNCE Jounce Therapeutics
$3.49 /

-0.06 (-1.69%)

IDYA Ideaya Biosciences
$9.31 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$47.66 /

+1.675 (+3.64%)

HOLX Hologic
$68.88 /

+1.17 (+1.73%)

HALO Halozyme
$39.63 /

+0.25 (+0.63%)

GILD Gilead
$65.11 /

+0.325 (+0.50%)

FATE Fate Therapeutics
$28.25 /

+0.935 (+3.42%)

DGX Quest Diagnostics
$130.17 /

+2.86 (+2.25%)

AVEO Aveo Pharmaceuticals
$8.59 /

+0.28 (+3.37%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

WAT Waters
$308.63 /

+6.55 (+2.17%)

SYK Stryker
$220.34 /

+9.14 (+4.33%)

GILD Gilead
$65.11 /

+0.325 (+0.50%)

ABBV AbbVie
$140.52 /

+1.48 (+1.06%)

On The Fly
What You Missed On Wall Street On Thursday » 16:43
09/08/22
09/08
16:43
09/08/22
16:43
FSLR

First Solar

$137.47 /

+2.71 (+2.01%)

, SPR

Spirit AeroSystems

$29.42 /

-0.23 (-0.78%)

, JPM

JPMorgan

$118.59 /

+2.67 (+2.30%)

, SWAV

ShockWave Medical

$292.67 /

+4.85 (+1.69%)

, TWTR

Twitter

$41.83 /

+0.61 (+1.48%)

, C

Citi

$49.90 /

+1.275 (+2.62%)

, REV

Revlon

$6.40 /

-0.33 (-4.90%)

, META

Meta Platforms

$162.11 /

+1.665 (+1.04%)

, MKC

McCormick

$79.29 /

-5.68 (-6.68%)

, GME

GameStop

$25.80 /

+1.73 (+7.19%)

, RIVN

Rivian Automotive

$36.88 /

+3.635 (+10.93%)

, DDAIF

Mercedes-Benz Group

/

+

, REGN

Regeneron

$709.21 /

+112.85 (+18.92%)

, AEO

American Eagle

$10.58 /

-1.01 (-8.72%)

, MQ

Marqeta

$7.37 /

-0.14 (-1.86%)

, FIS

FIS

$89.77 /

-1.13 (-1.24%)

, CDLX

Cardlytics

$12.03 /

-0.52 (-4.15%)

, MRNA

Moderna

$141.24 /

+6.325 (+4.69%)

, MGM

MGM Resorts

$34.05 /

+0.4625 (+1.38%)

, AMLX

Amylyx

$27.02 /

+9.15 (+51.20%)

, RVNC

Revance

$25.29 /

+4.53 (+21.82%)

, SNAP

Snap

$12.53 /

+1.07 (+9.34%)

, PLAY

Dave & Buster's

$37.71 /

-6.19 (-14.10%)

, SLVM

Sylvamo

$36.54 /

-3.865 (-9.57%)

, ASAN

Asana

$23.77 /

+4.66 (+24.39%)

, BILI

Bilibili

$20.07 /

-3.545 (-15.01%)

, BYRN

Byrna Technologies

$7.78 /

-0.655 (-7.77%)

, MCFT

MasterCraft Boat

$20.63 /

-3.12 (-13.14%)

, CPRT

Copart

$116.94 /

-1.85 (-1.56%)

Get caught up quickly on…

ShowHide Related Items >><<
TWTR Twitter
$41.83 /

+0.61 (+1.48%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SPR Spirit AeroSystems
$29.42 /

-0.23 (-0.78%)

SNAP Snap
$12.53 /

+1.07 (+9.34%)

SLVM Sylvamo
$36.54 /

-3.865 (-9.57%)

RVNC Revance
$25.29 /

+4.53 (+21.82%)

RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

REV Revlon
$6.40 /

-0.33 (-4.90%)

REGN Regeneron
$709.21 /

+112.85 (+18.92%)

PLAY Dave & Buster's
$37.71 /

-6.19 (-14.10%)

MRNA Moderna
$141.24 /

+6.325 (+4.69%)

MQ Marqeta
$7.37 /

-0.14 (-1.86%)

MKC McCormick
$79.29 /

-5.68 (-6.68%)

MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

MCFT MasterCraft Boat
$20.63 /

-3.12 (-13.14%)

JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

GME GameStop
$25.80 /

+1.73 (+7.19%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

FIS FIS
$89.77 /

-1.13 (-1.24%)

DDAIF Mercedes-Benz Group
/

+

CPRT Copart
$116.94 /

-1.85 (-1.56%)

CDLX Cardlytics
$12.03 /

-0.52 (-4.15%)

C Citi
$49.90 /

+1.275 (+2.62%)

BYRN Byrna Technologies
$7.78 /

-0.655 (-7.77%)

BILI Bilibili
$20.07 /

-3.545 (-15.01%)

ASAN Asana
$23.77 /

+4.66 (+24.39%)

AMLX Amylyx
$27.02 /

+9.15 (+51.20%)

AEO American Eagle
$10.58 /

-1.01 (-8.72%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

09/07/22 Goldman Sachs
First Solar upgraded to Buy from Sell at Goldman Sachs
08/31/22 BofA
First Solar price target raised to $152 from $141 at BofA
08/31/22 Baird
First Solar price target raised to $164 from $119 at Baird
08/26/22 BofA
BofA upgrades First Solar to Buy, sees 'too many ways to win IRA'
SPR Spirit AeroSystems
$29.42 /

-0.23 (-0.78%)

09/08/22 Morgan Stanley
Spirit AeroSystems downgraded to Underweight from Overweight at Morgan Stanley
08/18/22 BofA
Horizon Therapeutics and Spirit AeroSystems removed from US 1 List at BOFA
08/08/22 Cowen
Spirit AeroSystems price target lowered to $55 from $70
08/04/22 Morgan Stanley
Spirit AeroSystems price target lowered to $51 from $54 at Morgan Stanley
JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

07/18/22 Berenberg
JPMorgan upgraded to Hold from Sell at Berenberg
07/15/22 RBC Capital
JPMorgan price target lowered to $130 from $155 at RBC Capital
07/15/22 Evercore ISI
JPMorgan price target lowered to $125 from $135 at Evercore ISI
07/15/22 Oppenheimer
JPMorgan price target lowered to $153 from $154 at Oppenheimer
SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
TWTR Twitter
$41.83 /

+0.61 (+1.48%)

08/24/22 Gordon Haskett
Twitter whistleblower has no 'smoking gun,' says Gordon Haskett
08/24/22 Rosenblatt
Rosenblatt downgrades Twitter on risk of Musk using whistleblower suit
08/24/22 Rosenblatt
Twitter downgraded to Neutral from Buy at Rosenblatt
08/10/22 Gordon Haskett
Tesla sale shows Musk knows must come up with Twitter money, says Gordon Haskett
C Citi
$49.90 /

+1.275 (+2.62%)

09/06/22 Odeon Capital
Citi downgraded to Hold from Buy at Odeon Capital
07/18/22 Oppenheimer
Citi price target raised to $86 from $81 at Oppenheimer
07/18/22 UBS
Citi price target raised to $52 from $48 at UBS
07/17/22 Barclays
Citi price target lowered to $64 from $67 at Barclays
REV Revlon
$6.40 /

-0.33 (-4.90%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

08/22/22 Loop Capital
Meta Platforms price target lowered to $165 from $180 at Loop Capital
08/22/22 Loop Capital
Enovix price target raised to $100 from $50 at Loop Capital
08/19/22 Morgan Stanley
Meta Platforms price target lowered to $225 from $280 at Morgan Stanley
08/11/22 Loop Capital
Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
MKC McCormick
$79.29 /

-5.68 (-6.68%)

09/08/22 Deutsche Bank
McCormick price target lowered to $79 from $85 at Deutsche Bank
07/06/22 Argus
McCormick downgraded to Hold from Buy at Argus
06/30/22 Deutsche Bank
McCormick price target lowered to $85 from $91 at Deutsche Bank
06/21/22 Deutsche Bank
McCormick price target lowered to $91 from $99 at Deutsche Bank
GME GameStop
$25.80 /

+1.73 (+7.19%)

08/16/22 B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
07/22/22 Wedbush
GameStop price target lowered to $7.50 from $30 at Wedbush
05/26/22 Wedbush
Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
03/28/22 B. Riley
Bed Bath & Beyond price target raised to $26 from $19 at B. Riley
RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

09/08/22 RBC Capital
Rivian Automotive partnership should help save capital, says RBC Capital
08/24/22 Bernstein
Tesla, General Motors among big winners from IRA, says Bernstein
08/12/22 DA Davidson
Rivian Automotive price target raised to $27 from $24 at DA Davidson
08/12/22 Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
DDAIF Mercedes-Benz Group
/

+

07/29/22 RBC Capital
Mercedes-Benz Group price target raised to EUR 90 from EUR 89 at RBC Capital
07/07/22 UBS
Mercedes-Benz Group price target lowered to EUR 80 from EUR 90 at UBS
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/17/22 Bernstein
Mercedes-Benz Group initiated with an Outperform at Bernstein
REGN Regeneron
$709.21 /

+112.85 (+18.92%)

09/09/22 Morgan Stanley
Morgan Stanley upgrades Regeneron on 'significant upside' potential
09/09/22 Morgan Stanley
Regeneron upgraded to Overweight from Equal Weight at Morgan Stanley
09/08/22 Jefferies
Regeneron upgraded to Hold from Underperform at Jefferies
09/08/22 Piper Sandler
Regeneron data 'game changing,' will drive market share, says Piper
AEO American Eagle
$10.58 /

-1.01 (-8.72%)

09/08/22 Cowen
American Eagle price target lowered to $11 from $13 at Cowen
09/08/22 Citi
American Eagle price target lowered to $10 from $13 at Citi
08/01/22 Cowen
American Eagle downgraded to Market Perform from Outperform at Cowen
07/26/22 Deutsche Bank
Walmart outlook 'red flag for apparel,' says Deutsche Bank
MQ Marqeta
$7.37 /

-0.14 (-1.86%)

09/08/22 Wells Fargo
Marqeta downgraded to Underweight from Equal Weight at Wells Fargo
08/11/22 Wells Fargo
Wells Fargo downgrades Marqeta to Equal Weight, lowers price target to $11
08/11/22 Wells Fargo
Marqeta downgraded to Equal Weight from Overweight at Wells Fargo
08/04/22 Truist
Marqeta weakness on FIS confusion a buying opportunity, says Truist
FIS FIS
$89.77 /

-1.13 (-1.24%)

09/08/22 Wells Fargo
FIS downgraded to Underweight from Equal Weight at Wells Fargo
09/06/22 Baird
FIS price target raised to $122 from $120 at Baird
08/30/22 Susquehanna
Wells Fargo Payfac fading would open competition, says Susquehanna
08/09/22 Susquehanna
FIS price target lowered to $160 from $176 at Susquehanna
CDLX Cardlytics
$12.03 /

-0.52 (-4.15%)

09/08/22 Wells Fargo
Cardlytics downgraded to Underweight from Equal Weight at Wells Fargo
07/14/22 Wells Fargo
Cardlytics downgraded to Equal Weight from Overweight at Wells Fargo
07/14/22 Wells Fargo
Cardlytics downgraded to Equal Weight from Overweight at Wells Fargo
07/13/22 Needham
Cardlytics price target lowered to $24 from $60 at Needham
MRNA Moderna
$141.24 /

+6.325 (+4.69%)

09/07/22 Deutsche Bank
Moderna upgraded to Buy with $165 target at Deutsche Bank
09/07/22 Deutsche Bank
Moderna upgraded to Buy from Hold at Deutsche Bank
09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

09/08/22 Argus
MGM Resorts downgraded to Hold from Buy at Argus
09/08/22 Argus
MGM Resorts downgraded to Hold from Buy at Argus
09/07/22 JPMorgan
MGM Resorts shares 'represent good value,' says JPMorgan
08/04/22 Truist
MGM Resorts price target raised to $40 from $35 at Truist
AMLX Amylyx
$27.02 /

+9.15 (+51.20%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
RVNC Revance
$25.29 /

+4.53 (+21.82%)

09/09/22 H.C. Wainwright
Revance price target raised to $29 from $25 at H.C. Wainwright
09/08/22 Needham
Revance price target raised to $35 from $25 at Needham
09/08/22 Cowen
Revance price target raised to $65 from $55 at Cowen
09/08/22 Mizuho
Revance options imply 28% move on FDA decision, says Mizuho
SNAP Snap
$12.53 /

+1.07 (+9.34%)

09/08/22 UBS
UBS 'encouraged' by Snap's bullish targets for FY23
09/08/22 BofA
BofA 'encouraged by management's ambitions' after Snap CEO memo leak
09/01/22 RBC Capital
Snap price target raised to $11 from $10 at RBC Capital
09/01/22 Credit Suisse
Snap price target lowered to $29 from $35 at Credit Suisse
PLAY Dave & Buster's
$37.71 /

-6.19 (-14.10%)

09/08/22 Truist
Dave & Buster's price target raised to $62 from $57 at Truist
07/21/22 Raymond James
Dave & Buster's removed from Analyst Current Favorites list at Raymond James
07/13/22 Truist
Dave & Buster's price target lowered to $57 from $67 at Truist
07/13/22 Raymond James
Dave & Buster's price target lowered to $55 from $60 at Raymond James
SLVM Sylvamo
$36.54 /

-3.865 (-9.57%)

08/12/22 RBC Capital
Sylvamo price target raised to $55 from $45 at RBC Capital
04/07/22 RBC Capital
Sylvamo upgraded to Outperform at RBC Capital on continued paper pricing gains
04/07/22 RBC Capital
Sylvamo upgraded to Outperform from Sector Perform at RBC Capital
03/25/22 BofA
Sylvamo resumed at Neutral from Buy at BofA
ASAN Asana
$23.77 /

+4.66 (+24.39%)

09/08/22 Citi
Asana price target raised to $24 from $23 at Citi
09/08/22 RBC Capital
Asana price target raised to $15 from $13 at RBC Capital
09/08/22 Piper Sandler
Piper ups Asana target, says funding should 'quiet bear concerns'
09/01/22 Citi
Asana initiated with a Neutral at Citi
BILI Bilibili
$20.07 /

-3.545 (-15.01%)

09/08/22 Citi
Bilibili price target lowered to $38 from $45 at Citi
09/07/22 JPMorgan
Bilibili assumed at Overweight from Neutral at JPMorgan
08/01/22 Goldman Sachs
Bilibili received one China game approval for August, says Goldman Sachs
06/13/22 JPMorgan
Bilibili price target raised to $25 from $19 at JPMorgan
BYRN Byrna Technologies
$7.78 /

-0.655 (-7.77%)

09/08/22 Dawson James
Byrna Technologies price target lowered to $9.50 from $12 at Dawson James
06/24/22 Dawson James
Supreme Court ruling on NY could be positive for Byrna growth, says Dawson James
05/18/22 Dawson James
Byrna Technologies news 'very positive,' says Dawson James
04/26/22 Dawson James
Byrna Technologies initiated with a Buy at Dawson James
MCFT MasterCraft Boat
$20.63 /

-3.12 (-13.14%)

08/18/22 Stifel
MasterCraft Boat initiated with a Buy at Stifel
07/18/22 Baird
MasterCraft Boat price target lowered to $32 from $36 at Baird
06/21/22 B. Riley
MasterCraft Boat price target lowered to $41 from $47 at B. Riley
05/12/22 Baird
MasterCraft Boat price target lowered to $36 from $40 at Baird
CPRT Copart
$116.94 /

-1.85 (-1.56%)

03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
02/18/22 Baird
Copart price target lowered to $160 from $170 at Baird
11/19/21 Truist
Copart price target raised to $175 from $160 at Truist
09/10/21 Truist
Copart price target raised to $160 from $145 at Truist
TWTR Twitter
$41.83 /

+0.61 (+1.48%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SPR Spirit AeroSystems
$29.42 /

-0.23 (-0.78%)

SNAP Snap
$12.53 /

+1.07 (+9.34%)

SLVM Sylvamo
$36.54 /

-3.865 (-9.57%)

RVNC Revance
$25.29 /

+4.53 (+21.82%)

RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

REV Revlon
$6.40 /

-0.33 (-4.90%)

REGN Regeneron
$709.21 /

+112.85 (+18.92%)

PLAY Dave & Buster's
$37.71 /

-6.19 (-14.10%)

MRNA Moderna
$141.24 /

+6.325 (+4.69%)

MQ Marqeta
$7.37 /

-0.14 (-1.86%)

MKC McCormick
$79.29 /

-5.68 (-6.68%)

MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

MCFT MasterCraft Boat
$20.63 /

-3.12 (-13.14%)

JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

GME GameStop
$25.80 /

+1.73 (+7.19%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

FIS FIS
$89.77 /

-1.13 (-1.24%)

DDAIF Mercedes-Benz Group
/

+

CPRT Copart
$116.94 /

-1.85 (-1.56%)

CDLX Cardlytics
$12.03 /

-0.52 (-4.15%)

C Citi
$49.90 /

+1.275 (+2.62%)

BYRN Byrna Technologies
$7.78 /

-0.655 (-7.77%)

BILI Bilibili
$20.07 /

-3.545 (-15.01%)

ASAN Asana
$23.77 /

+4.66 (+24.39%)

AMLX Amylyx
$27.02 /

+9.15 (+51.20%)

AEO American Eagle
$10.58 /

-1.01 (-8.72%)

  • 08
    Sep
  • 07
    Jan
  • 10
    Nov
TWTR Twitter
$41.83 /

+0.61 (+1.48%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

SNAP Snap
$12.53 /

+1.07 (+9.34%)

RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

REV Revlon
$6.40 /

-0.33 (-4.90%)

MRNA Moderna
$141.24 /

+6.325 (+4.69%)

MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

GME GameStop
$25.80 /

+1.73 (+7.19%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

CPRT Copart
$116.94 /

-1.85 (-1.56%)

C Citi
$49.90 /

+1.275 (+2.62%)

BILI Bilibili
$20.07 /

-3.545 (-15.01%)

AMLX Amylyx
$27.02 /

+9.15 (+51.20%)

AEO American Eagle
$10.58 /

-1.01 (-8.72%)

TWTR Twitter
$41.83 /

+0.61 (+1.48%)

SWAV ShockWave Medical
$292.67 /

+4.85 (+1.69%)

RVNC Revance
$25.29 /

+4.53 (+21.82%)

RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

REV Revlon
$6.40 /

-0.33 (-4.90%)

REGN Regeneron
$709.21 /

+112.85 (+18.92%)

PLAY Dave & Buster's
$37.71 /

-6.19 (-14.10%)

MRNA Moderna
$141.24 /

+6.325 (+4.69%)

MQ Marqeta
$7.37 /

-0.14 (-1.86%)

MKC McCormick
$79.29 /

-5.68 (-6.68%)

MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

MCFT MasterCraft Boat
$20.63 /

-3.12 (-13.14%)

JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

FIS FIS
$89.77 /

-1.13 (-1.24%)

DDAIF Mercedes-Benz Group
/

+

CDLX Cardlytics
$12.03 /

-0.52 (-4.15%)

C Citi
$49.90 /

+1.275 (+2.62%)

BYRN Byrna Technologies
$7.78 /

-0.655 (-7.77%)

TWTR Twitter
$41.83 /

+0.61 (+1.48%)

SNAP Snap
$12.53 /

+1.07 (+9.34%)

RIVN Rivian Automotive
$36.88 /

+3.635 (+10.93%)

REV Revlon
$6.40 /

-0.33 (-4.90%)

REGN Regeneron
$709.21 /

+112.85 (+18.92%)

PLAY Dave & Buster's
$37.71 /

-6.19 (-14.10%)

MRNA Moderna
$141.24 /

+6.325 (+4.69%)

MQ Marqeta
$7.37 /

-0.14 (-1.86%)

MGM MGM Resorts
$34.05 /

+0.4625 (+1.38%)

META Meta Platforms
$162.11 /

+1.665 (+1.04%)

JPM JPMorgan
$118.59 /

+2.67 (+2.30%)

GME GameStop
$25.80 /

+1.73 (+7.19%)

FSLR First Solar
$137.47 /

+2.71 (+2.01%)

C Citi
$49.90 /

+1.275 (+2.62%)

BILI Bilibili
$20.07 /

-3.545 (-15.01%)

ASAN Asana
$23.77 /

+4.66 (+24.39%)

AMLX Amylyx
$27.02 /

+9.15 (+51.20%)

AEO American Eagle
$10.58 /

-1.01 (-8.72%)

On The Fly
What You Missed On Wall Street This Morning » 12:14
09/08/22
09/08
12:14
09/08/22
12:14
GME

GameStop

$25.85 /

+1.78 (+7.40%)

, RIVN

Rivian Automotive

$35.72 /

+2.475 (+7.44%)

, MKC

McCormick

$78.66 /

-6.31 (-7.43%)

, DDAIF

Mercedes-Benz Group

/

+

, AEO

American Eagle

$10.44 /

-1.145 (-9.88%)

, REGN

Regeneron

$702.98 /

+106.62 (+17.88%)

, FSLR

First Solar

$136.46 /

+1.7 (+1.26%)

, SPR

Spirit AeroSystems

$29.27 /

-0.38 (-1.28%)

, MQ

Marqeta

$7.29 /

-0.22 (-2.93%)

, MRNA

Moderna

$140.73 /

+5.82 (+4.31%)

, FIS

FIS

$89.88 /

-1.02 (-1.12%)

, CDLX

Cardlytics

$12.14 /

-0.405 (-3.23%)

, MGM

MGM Resorts

$33.61 /

+0.0225 (+0.07%)

, JPM

JPMorgan

$118.11 /

+2.19 (+1.89%)

, SWAV

ShockWave Medical

$297.30 /

+9.48 (+3.29%)

, AMZN

Amazon.com

$129.25 /

-0.22 (-0.17%)

, SPOT

Spotify

$105.92 /

-0.02 (-0.02%)

, AAPL

Apple

$155.57 /

-0.39 (-0.25%)

, BBBY

Bed Bath & Beyond

$8.13 /

+0.235 (+2.98%)

, AMLX

Amylyx

$27.42 /

+9.55 (+53.44%)

, RVNC

Revance

$23.62 /

+2.86 (+13.78%)

, SNAP

Snap

$12.32 /

+0.86 (+7.50%)

, PLAY

Dave & Buster's

$39.09 /

-4.81 (-10.96%)

, SLVM

Sylvamo

$36.48 /

-3.92 (-9.70%)

, ASAN

Asana

$23.42 /

+4.31 (+22.55%)

, BILI

Bilibili

$19.50 /

-4.11 (-17.41%)

, BYRN

Byrna Technologies

$8.25 /

-0.18 (-2.14%)

, MCFT

MasterCraft Boat

$20.55 /

-3.2 (-13.47%)

, CPRT

Copart

$116.54 /

-2.25 (-1.89%)

Get caught up quickly on…

ShowHide Related Items >><<
SWAV ShockWave Medical
$297.30 /

+9.48 (+3.29%)

SPR Spirit AeroSystems
$29.27 /

-0.38 (-1.28%)

SPOT Spotify
$105.92 /

-0.02 (-0.02%)

SNAP Snap
$12.32 /

+0.86 (+7.50%)

SLVM Sylvamo
$36.48 /

-3.92 (-9.70%)

RVNC Revance
$23.62 /

+2.86 (+13.78%)

RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

REGN Regeneron
$702.98 /

+106.62 (+17.88%)

PLAY Dave & Buster's
$39.09 /

-4.81 (-10.96%)

MRNA Moderna
$140.73 /

+5.82 (+4.31%)

MQ Marqeta
$7.29 /

-0.22 (-2.93%)

MKC McCormick
$78.66 /

-6.31 (-7.43%)

MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

MCFT MasterCraft Boat
$20.55 /

-3.2 (-13.47%)

JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

FSLR First Solar
$136.46 /

+1.7 (+1.26%)

FIS FIS
$89.88 /

-1.02 (-1.12%)

DDAIF Mercedes-Benz Group
/

+

CPRT Copart
$116.54 /

-2.25 (-1.89%)

CDLX Cardlytics
$12.14 /

-0.405 (-3.23%)

BYRN Byrna Technologies
$8.25 /

-0.18 (-2.14%)

BILI Bilibili
$19.50 /

-4.11 (-17.41%)

BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

ASAN Asana
$23.42 /

+4.31 (+22.55%)

AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

AEO American Eagle
$10.44 /

-1.145 (-9.88%)

AAPL Apple
$155.57 /

-0.39 (-0.25%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

08/16/22 B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
07/22/22 Wedbush
GameStop price target lowered to $7.50 from $30 at Wedbush
05/26/22 Wedbush
Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
03/28/22 B. Riley
Bed Bath & Beyond price target raised to $26 from $19 at B. Riley
RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

09/08/22 RBC Capital
Rivian Automotive partnership should help save capital, says RBC Capital
08/24/22 Bernstein
Tesla, General Motors among big winners from IRA, says Bernstein
08/12/22 DA Davidson
Rivian Automotive price target raised to $27 from $24 at DA Davidson
08/12/22 Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
MKC McCormick
$78.66 /

-6.31 (-7.43%)

09/08/22 Deutsche Bank
McCormick price target lowered to $79 from $85 at Deutsche Bank
07/06/22 Argus
McCormick downgraded to Hold from Buy at Argus
06/30/22 Deutsche Bank
McCormick price target lowered to $85 from $91 at Deutsche Bank
06/21/22 Deutsche Bank
McCormick price target lowered to $91 from $99 at Deutsche Bank
DDAIF Mercedes-Benz Group
/

+

07/29/22 RBC Capital
Mercedes-Benz Group price target raised to EUR 90 from EUR 89 at RBC Capital
07/07/22 UBS
Mercedes-Benz Group price target lowered to EUR 80 from EUR 90 at UBS
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/17/22 Bernstein
Mercedes-Benz Group initiated with an Outperform at Bernstein
AEO American Eagle
$10.44 /

-1.145 (-9.88%)

09/08/22 Cowen
American Eagle price target lowered to $11 from $13 at Cowen
09/08/22 Citi
American Eagle price target lowered to $10 from $13 at Citi
08/01/22 Cowen
American Eagle downgraded to Market Perform from Outperform at Cowen
07/26/22 Deutsche Bank
Walmart outlook 'red flag for apparel,' says Deutsche Bank
REGN Regeneron
$702.98 /

+106.62 (+17.88%)

09/08/22 Piper Sandler
Regeneron data 'game changing,' will drive market share, says Piper
09/08/22 BMO Capital
High-dose Eylea data 'best case scenario' for Regeneron, says BMO Capital
09/08/22 RBC Capital
RBC says Regeneron's Eylea data should help reduce some durability overhangs
08/04/22 BMO Capital
Regeneron price target raised to $788 from $757 at BMO Capital
FSLR First Solar
$136.46 /

+1.7 (+1.26%)

09/07/22 Goldman Sachs
First Solar upgraded to Buy from Sell at Goldman Sachs
08/31/22 BofA
First Solar price target raised to $152 from $141 at BofA
08/31/22 Baird
First Solar price target raised to $164 from $119 at Baird
08/26/22 BofA
BofA upgrades First Solar to Buy, sees 'too many ways to win IRA'
SPR Spirit AeroSystems
$29.27 /

-0.38 (-1.28%)

09/08/22 Morgan Stanley
Spirit AeroSystems downgraded to Underweight from Overweight at Morgan Stanley
08/18/22 BofA
Horizon Therapeutics and Spirit AeroSystems removed from US 1 List at BOFA
08/08/22 Cowen
Spirit AeroSystems price target lowered to $55 from $70
08/04/22 Morgan Stanley
Spirit AeroSystems price target lowered to $51 from $54 at Morgan Stanley
MQ Marqeta
$7.29 /

-0.22 (-2.93%)

09/08/22 Wells Fargo
Marqeta downgraded to Underweight from Equal Weight at Wells Fargo
08/11/22 Wells Fargo
Wells Fargo downgrades Marqeta to Equal Weight, lowers price target to $11
08/11/22 Wells Fargo
Marqeta downgraded to Equal Weight from Overweight at Wells Fargo
08/04/22 Truist
Marqeta weakness on FIS confusion a buying opportunity, says Truist
MRNA Moderna
$140.73 /

+5.82 (+4.31%)

09/07/22 Deutsche Bank
Moderna upgraded to Buy with $165 target at Deutsche Bank
09/07/22 Deutsche Bank
Moderna upgraded to Buy from Hold at Deutsche Bank
09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
FIS FIS
$89.88 /

-1.02 (-1.12%)

09/08/22 Wells Fargo
FIS downgraded to Underweight from Equal Weight at Wells Fargo
09/06/22 Baird
FIS price target raised to $122 from $120 at Baird
08/30/22 Susquehanna
Wells Fargo Payfac fading would open competition, says Susquehanna
08/09/22 Susquehanna
FIS price target lowered to $160 from $176 at Susquehanna
CDLX Cardlytics
$12.14 /

-0.405 (-3.23%)

09/08/22 Wells Fargo
Cardlytics downgraded to Underweight from Equal Weight at Wells Fargo
07/14/22 Wells Fargo
Cardlytics downgraded to Equal Weight from Overweight at Wells Fargo
07/14/22 Wells Fargo
Cardlytics downgraded to Equal Weight from Overweight at Wells Fargo
07/13/22 Needham
Cardlytics price target lowered to $24 from $60 at Needham
MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

09/08/22 Argus
MGM Resorts downgraded to Hold from Buy at Argus
09/08/22 Argus
MGM Resorts downgraded to Hold from Buy at Argus
09/07/22 JPMorgan
MGM Resorts shares 'represent good value,' says JPMorgan
08/04/22 Truist
MGM Resorts price target raised to $40 from $35 at Truist
JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

07/18/22 Berenberg
JPMorgan upgraded to Hold from Sell at Berenberg
07/15/22 RBC Capital
JPMorgan price target lowered to $130 from $155 at RBC Capital
07/15/22 Evercore ISI
JPMorgan price target lowered to $125 from $135 at Evercore ISI
07/15/22 Oppenheimer
JPMorgan price target lowered to $153 from $154 at Oppenheimer
SWAV ShockWave Medical
$297.30 /

+9.48 (+3.29%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

08/29/22 Citi
Amazon deal for Electronic Arts would bring regulatory risks, says Citi
08/26/22 Benchmark
EA could be valued at $188 per share in competitive process, says Benchmark
08/26/22 Craig-Hallum
Plug Power price target raised to $38 from $31 at Craig-Hallum
08/25/22 Canaccord
Peloton price target lowered to $20 from $25 at Canaccord
SPOT Spotify
$105.92 /

-0.02 (-0.02%)

07/28/22 Citi
Spotify price target lowered to $145 from $150 at Citi
07/28/22 Pivotal Research
Spotify rally on Q2 results an overreaction, says Pivotal Research
07/27/22 KeyBanc
Spotify price target raised to $148 at KeyBanc after 'better than feared' Q2
07/25/22 Morgan Stanley
Spotify price target lowered to $140 from $170 at Morgan Stanley
AAPL Apple
$155.57 /

-0.39 (-0.25%)

09/08/22 William Blair
William Blair says buy Iridium on selloff from Apple, Globalstar pact
09/08/22 BWS Financial
BWS says competing handset makers following Apple opens door for Iridium
09/08/22 B. Riley
B. Riley sees 'ample value' in Globalstar shares after Apple pact
09/08/22 Oppenheimer
Apple integrated approach to design has little competition, says Oppenheimer
BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
09/01/22 Raymond James
Bed Bath & Beyond downgraded to Underperform from Market Perform at Raymond James
08/18/22 Wedbush
Wedbush downgrades Bed Bath & Beyond to sell on Cohen exit signal
AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
RVNC Revance
$23.62 /

+2.86 (+13.78%)

09/08/22 Needham
Revance price target raised to $35 from $25 at Needham
09/08/22 Cowen
Revance price target raised to $65 from $55 at Cowen
09/08/22 Mizuho
Revance options imply 28% move on FDA decision, says Mizuho
08/25/22 Wells Fargo
Revance price target raised to $24 from $17 at Wells Fargo
SNAP Snap
$12.32 /

+0.86 (+7.50%)

09/08/22 UBS
UBS 'encouraged' by Snap's bullish targets for FY23
09/08/22 BofA
BofA 'encouraged by management's ambitions' after Snap CEO memo leak
09/01/22 RBC Capital
Snap price target raised to $11 from $10 at RBC Capital
09/01/22 Credit Suisse
Snap price target lowered to $29 from $35 at Credit Suisse
PLAY Dave & Buster's
$39.09 /

-4.81 (-10.96%)

09/08/22 Truist
Dave & Buster's price target raised to $62 from $57 at Truist
07/21/22 Raymond James
Dave & Buster's removed from Analyst Current Favorites list at Raymond James
07/13/22 Truist
Dave & Buster's price target lowered to $57 from $67 at Truist
07/13/22 Raymond James
Dave & Buster's price target lowered to $55 from $60 at Raymond James
SLVM Sylvamo
$36.48 /

-3.92 (-9.70%)

08/12/22 RBC Capital
Sylvamo price target raised to $55 from $45 at RBC Capital
04/07/22 RBC Capital
Sylvamo upgraded to Outperform at RBC Capital on continued paper pricing gains
04/07/22 RBC Capital
Sylvamo upgraded to Outperform from Sector Perform at RBC Capital
03/25/22 BofA
Sylvamo resumed at Neutral from Buy at BofA
ASAN Asana
$23.42 /

+4.31 (+22.55%)

09/08/22 Citi
Asana price target raised to $24 from $23 at Citi
09/08/22 RBC Capital
Asana price target raised to $15 from $13 at RBC Capital
09/08/22 Piper Sandler
Piper ups Asana target, says funding should 'quiet bear concerns'
09/01/22 Citi
Asana initiated with a Neutral at Citi
BILI Bilibili
$19.50 /

-4.11 (-17.41%)

09/07/22 JPMorgan
Bilibili assumed at Overweight from Neutral at JPMorgan
08/01/22 Goldman Sachs
Bilibili received one China game approval for August, says Goldman Sachs
06/13/22 JPMorgan
Bilibili price target raised to $25 from $19 at JPMorgan
06/10/22 Citi
Bilibili price target lowered to $45 from $46 at Citi
BYRN Byrna Technologies
$8.25 /

-0.18 (-2.14%)

09/08/22 Dawson James
Byrna Technologies price target lowered to $9.50 from $12 at Dawson James
06/24/22 Dawson James
Supreme Court ruling on NY could be positive for Byrna growth, says Dawson James
05/18/22 Dawson James
Byrna Technologies news 'very positive,' says Dawson James
04/26/22 Dawson James
Byrna Technologies initiated with a Buy at Dawson James
MCFT MasterCraft Boat
$20.55 /

-3.2 (-13.47%)

08/18/22 Stifel
MasterCraft Boat initiated with a Buy at Stifel
07/18/22 Baird
MasterCraft Boat price target lowered to $32 from $36 at Baird
06/21/22 B. Riley
MasterCraft Boat price target lowered to $41 from $47 at B. Riley
05/12/22 Baird
MasterCraft Boat price target lowered to $36 from $40 at Baird
CPRT Copart
$116.54 /

-2.25 (-1.89%)

03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
02/18/22 Baird
Copart price target lowered to $160 from $170 at Baird
11/19/21 Truist
Copart price target raised to $175 from $160 at Truist
09/10/21 Truist
Copart price target raised to $160 from $145 at Truist
SWAV ShockWave Medical
$297.30 /

+9.48 (+3.29%)

SPR Spirit AeroSystems
$29.27 /

-0.38 (-1.28%)

SPOT Spotify
$105.92 /

-0.02 (-0.02%)

SNAP Snap
$12.32 /

+0.86 (+7.50%)

SLVM Sylvamo
$36.48 /

-3.92 (-9.70%)

RVNC Revance
$23.62 /

+2.86 (+13.78%)

RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

REGN Regeneron
$702.98 /

+106.62 (+17.88%)

PLAY Dave & Buster's
$39.09 /

-4.81 (-10.96%)

MRNA Moderna
$140.73 /

+5.82 (+4.31%)

MQ Marqeta
$7.29 /

-0.22 (-2.93%)

MKC McCormick
$78.66 /

-6.31 (-7.43%)

MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

MCFT MasterCraft Boat
$20.55 /

-3.2 (-13.47%)

JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

FSLR First Solar
$136.46 /

+1.7 (+1.26%)

FIS FIS
$89.88 /

-1.02 (-1.12%)

DDAIF Mercedes-Benz Group
/

+

CPRT Copart
$116.54 /

-2.25 (-1.89%)

CDLX Cardlytics
$12.14 /

-0.405 (-3.23%)

BYRN Byrna Technologies
$8.25 /

-0.18 (-2.14%)

BILI Bilibili
$19.50 /

-4.11 (-17.41%)

BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

ASAN Asana
$23.42 /

+4.31 (+22.55%)

AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

AEO American Eagle
$10.44 /

-1.145 (-9.88%)

AAPL Apple
$155.57 /

-0.39 (-0.25%)

  • 08
    Sep
  • 07
    Jan
  • 10
    Nov
SWAV ShockWave Medical
$297.30 /

+9.48 (+3.29%)

SPOT Spotify
$105.92 /

-0.02 (-0.02%)

SNAP Snap
$12.32 /

+0.86 (+7.50%)

RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

MRNA Moderna
$140.73 /

+5.82 (+4.31%)

MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

FSLR First Solar
$136.46 /

+1.7 (+1.26%)

CPRT Copart
$116.54 /

-2.25 (-1.89%)

BILI Bilibili
$19.50 /

-4.11 (-17.41%)

BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

AEO American Eagle
$10.44 /

-1.145 (-9.88%)

AAPL Apple
$155.57 /

-0.39 (-0.25%)

SWAV ShockWave Medical
$297.30 /

+9.48 (+3.29%)

SPOT Spotify
$105.92 /

-0.02 (-0.02%)

SNAP Snap
$12.32 /

+0.86 (+7.50%)

RVNC Revance
$23.62 /

+2.86 (+13.78%)

RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

REGN Regeneron
$702.98 /

+106.62 (+17.88%)

PLAY Dave & Buster's
$39.09 /

-4.81 (-10.96%)

MRNA Moderna
$140.73 /

+5.82 (+4.31%)

MQ Marqeta
$7.29 /

-0.22 (-2.93%)

MKC McCormick
$78.66 /

-6.31 (-7.43%)

MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

MCFT MasterCraft Boat
$20.55 /

-3.2 (-13.47%)

JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

FSLR First Solar
$136.46 /

+1.7 (+1.26%)

FIS FIS
$89.88 /

-1.02 (-1.12%)

DDAIF Mercedes-Benz Group
/

+

CDLX Cardlytics
$12.14 /

-0.405 (-3.23%)

BYRN Byrna Technologies
$8.25 /

-0.18 (-2.14%)

BILI Bilibili
$19.50 /

-4.11 (-17.41%)

BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

ASAN Asana
$23.42 /

+4.31 (+22.55%)

AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

AEO American Eagle
$10.44 /

-1.145 (-9.88%)

AAPL Apple
$155.57 /

-0.39 (-0.25%)

SPOT Spotify
$105.92 /

-0.02 (-0.02%)

SNAP Snap
$12.32 /

+0.86 (+7.50%)

RIVN Rivian Automotive
$35.72 /

+2.475 (+7.44%)

REGN Regeneron
$702.98 /

+106.62 (+17.88%)

PLAY Dave & Buster's
$39.09 /

-4.81 (-10.96%)

MRNA Moderna
$140.73 /

+5.82 (+4.31%)

MQ Marqeta
$7.29 /

-0.22 (-2.93%)

MGM MGM Resorts
$33.61 /

+0.0225 (+0.07%)

JPM JPMorgan
$118.11 /

+2.19 (+1.89%)

GME GameStop
$25.85 /

+1.78 (+7.40%)

FSLR First Solar
$136.46 /

+1.7 (+1.26%)

BILI Bilibili
$19.50 /

-4.11 (-17.41%)

BBBY Bed Bath & Beyond
$8.13 /

+0.235 (+2.98%)

ASAN Asana
$23.42 /

+4.31 (+22.55%)

AMZN Amazon.com
$129.25 /

-0.22 (-0.17%)

AMLX Amylyx
$27.42 /

+9.55 (+53.44%)

AEO American Eagle
$10.44 /

-1.145 (-9.88%)

AAPL Apple
$155.57 /

-0.39 (-0.25%)

Periodicals
ShockWave called a 'name to watch' by Dealreporter on M&A potential » 09:49
09/08/22
09/08
09:49
09/08/22
09:49
SWAV

ShockWave Medical

$284.11 /

-3.71 (-1.29%)

, JNJ

Johnson & Johnson

$163.32 /

-0.78 (-0.48%)

In a flash note to its…

In a flash note to its subscribers, Dealreporter quoted Ashley McEvoy, Johnson & Johnson's (JNJ) EVP and worldwide chairman of medtech, as having said "We love M&A" and went on to say "one name came to mind for us should JNJ look to significantly grow its business in the neurovascular arena," contacts tell The Fly. That name is Shockwave Medical (SWAV), which the deal-focused publication called "a name to watch going forward," while noting that Shockwave saw "takeover interest earlier this year" and that J&J appears to be "on the hunt for new growth areas in stroke," contacts tell The Fly.

ShowHide Related Items >><<
SWAV ShockWave Medical
$284.11 /

-3.71 (-1.29%)

JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

SWAV ShockWave Medical
$284.11 /

-3.71 (-1.29%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

07/21/22 UBS
Johnson & Johnson price target lowered to $180 from $185 at UBS
07/20/22 SVB Securities
Johnson & Johnson price target lowered to $194 from $200 at SVB Securities
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Citi
Johnson & Johnson price target lowered to $201 from $205 at Citi
SWAV ShockWave Medical
$284.11 /

-3.71 (-1.29%)

JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

SWAV ShockWave Medical
$284.11 /

-3.71 (-1.29%)

JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

JNJ Johnson & Johnson
$163.32 /

-0.78 (-0.48%)

Conference/Events
Wells Fargo to hold a conference » 04:55
09/08/22
09/08
04:55
09/08/22
04:55
ABBV

AbbVie

$139.04 /

+1.4 (+1.02%)

, AVEO

Aveo Pharmaceuticals

$8.31 /

+0.33 (+4.14%)

, BNFT

Benefitfocus

$7.04 /

+0.33 (+4.92%)

, DGX

Quest Diagnostics

$127.38 /

+2.27 (+1.81%)

, FATE

Fate Therapeutics

$27.31 /

+2.02 (+7.99%)

, INSP

Inspire Medical

$188.93 /

+5.92 (+3.23%)

, LEGN

Legend Biotech

$43.86 /

-0.17 (-0.39%)

, GILD

Gilead

$64.79 /

+1.355 (+2.14%)

, HOLX

Hologic

$67.71 /

+0.33 (+0.49%)

, INGN

Inogen

$28.19 /

+0.6 (+2.17%)

, KYMR

Kymera Therapeutics

$28.47 /

+2.545 (+9.82%)

, NOTV

Inotiv

$20.88 /

+0.24 (+1.16%)

, PEN

Penumbra

$186.16 /

+21.935 (+13.36%)

, RGLS

Regulus

$1.57 /

-0.01 (-0.63%)

, SWAV

ShockWave Medical

$286.96 /

+12.165 (+4.43%)

, WAT

Waters

$302.21 /

+4.705 (+1.58%)

, SUPN

Supernus

$34.19 /

+0.15 (+0.44%)

, ORIC

Oric Pharmaceuticals

$3.46 /

-0.09 (-2.54%)

, PGEN

Precigen

$2.31 /

+0.025 (+1.09%)

, NRIX

Nurix Therapeutics

$16.12 /

+0.83 (+5.43%)

, NUVA

NuVasive

$45.32 /

+2.34 (+5.44%)

, AUTL

Autolus Therapeutics

$2.94 /

-0.15 (-4.85%)

, HALO

Halozyme

$39.39 /

+0.845 (+2.19%)

, IMVT

Immunovant

$4.92 /

+0.03 (+0.61%)

, JNCE

Jounce Therapeutics

$3.55 /

+0.05 (+1.43%)

, IDYA

Ideaya Biosciences

$9.29 /

+0.05 (+0.54%)

, SYK

Stryker

$211.20 /

+8.39 (+4.14%)

, NPCE

NeuroPace

$4.73 /

+0.01 (+0.21%)

, IONS

Ionis Pharmaceuticals

$43.43 /

+1.75 (+4.20%)

, HRMY

Harmony Biosciences

$46.06 /

+1.7 (+3.83%)

2022 Wells Fargo…

2022 Wells Fargo Healthcare Conference to be held in Everett, MA on September 7-9.

ShowHide Related Items >><<
SYK Stryker
$211.20 /

+8.39 (+4.14%)

SWAV ShockWave Medical
$286.96 /

+12.165 (+4.43%)

SUPN Supernus
$34.19 /

+0.15 (+0.44%)

RGLS Regulus
$1.57 /

-0.01 (-0.63%)

PGEN Precigen
$2.31 /

+0.025 (+1.09%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.32 /

+2.34 (+5.44%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

NOTV Inotiv
$20.88 /

+0.24 (+1.16%)

LEGN Legend Biotech
$43.86 /

-0.17 (-0.39%)

KYMR Kymera Therapeutics
$28.47 /

+2.545 (+9.82%)

JNCE Jounce Therapeutics
$3.55 /

+0.05 (+1.43%)

IONS Ionis Pharmaceuticals
$43.43 /

+1.75 (+4.20%)

INSP Inspire Medical
$188.93 /

+5.92 (+3.23%)

IMVT Immunovant
$4.92 /

+0.03 (+0.61%)

IDYA Ideaya Biosciences
$9.29 /

+0.05 (+0.54%)

HRMY Harmony Biosciences
$46.06 /

+1.7 (+3.83%)

HOLX Hologic
$67.71 /

+0.33 (+0.49%)

HALO Halozyme
$39.39 /

+0.845 (+2.19%)

GILD Gilead
$64.79 /

+1.355 (+2.14%)

FATE Fate Therapeutics
$27.31 /

+2.02 (+7.99%)

DGX Quest Diagnostics
$127.38 /

+2.27 (+1.81%)

BNFT Benefitfocus
$7.04 /

+0.33 (+4.92%)

AVEO Aveo Pharmaceuticals
$8.31 /

+0.33 (+4.14%)

AUTL Autolus Therapeutics
$2.94 /

-0.15 (-4.85%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

08/30/22 Piper Sandler
I-Mab price target lowered to $30 from $35 at Piper Sandler
08/24/22 Argus
AbbVie price target lowered to $155 from $165 at Argus
08/01/22 JPMorgan
AbbVie selloff Friday a buying opportunity, says JPMorgan
08/01/22 Barclays
AbbVie price target lowered to $160 from $174 at Barclays
AVEO Aveo Pharmaceuticals
$8.31 /

+0.33 (+4.14%)

03/14/22 JonesTrading
Aveo Pharmaceuticals initiated with a Buy at JonesTrading
BNFT Benefitfocus
$7.04 /

+0.33 (+4.92%)

09/06/22 Piper Sandler
Benefitfocus price target lowered to $6 from $9 at Piper Sandler
06/22/22 Piper Sandler
Benefitfocus downgraded to Neutral from Overweight at Piper Sandler
DGX Quest Diagnostics
$127.38 /

+2.27 (+1.81%)

08/22/22 Morgan Stanley
Quest Diagnostics assumed with an Equal Weight at Morgan Stanley
07/22/22 Mizuho
Quest Diagnostics price target lowered to $160 from $185 at Mizuho
07/22/22 Credit Suisse
Quest Diagnostics price target lowered to $143 from $158 at Credit Suisse
04/24/22 UBS
Quest Diagnostics price target raised to $150 from $139 at UBS
FATE Fate Therapeutics
$27.31 /

+2.02 (+7.99%)

08/18/22 Wells Fargo
Fate Therapeutics assumed with an Overweight at Wells Fargo
08/04/22 Oppenheimer
Fate Therapeutics price target lowered to $90 from $135 at Oppenheimer
07/28/22 Needham
Fate Therapeutics initiated with a Hold at Needham
07/11/22 BMO Capital
Fate Therapeutics upgraded to Outperform from Market Perform at BMO Capital
INSP Inspire Medical
$188.93 /

+5.92 (+3.23%)

08/03/22 Truist
Inspire Medical price target raised to $280 from $250 at Truist
08/03/22 Piper Sandler
Inspire Medical price target lowered to $285 from $310 at Piper Sandler
07/05/22 Piper Sandler
Piper says Inspire appears to have received FDA approval for expanded labeling
06/10/22 Truist
Inspire Medical price target lowered to $250 from $296 at Truist
LEGN Legend Biotech
$43.86 /

-0.17 (-0.39%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/16/22 BMO Capital
Legend Biotech initiated with an Outperform at BMO Capital
05/31/22 Morgan Stanley
Legend Biotech named Catalyst Driven Idea by Morgan Stanley
03/15/22 Barclays
Legend Biotech initiated with an Overweight at Barclays
GILD Gilead
$64.79 /

+1.355 (+2.14%)

09/02/22 Argus
Gilead pullback provides favorable entry point, says Argus
08/15/22 Piper Sandler
Gilead's Trodelvy shows OS benefit in HR+/HER- BC, says Piper Sandler
08/15/22 Piper Sandler
Gilead price target raised to $74 from $71 at Piper Sandler
08/08/22 Truist
Gilead price target lowered to $71 from $75 at Truist
HOLX Hologic
$67.71 /

+0.33 (+0.49%)

07/22/22 Evercore ISI
Intuitive Surgical price target lowered to $175 from $210 at Evercore ISI
07/20/22 UBS
Hologic initiated with a Neutral at UBS
07/20/22 BofA
BofA cuts Hologic to Neutral amid difficult macro, ongoing supply chain issues
07/20/22 BofA
Hologic downgraded to Neutral from Buy at BofA
INGN Inogen
$28.19 /

+0.6 (+2.17%)

05/09/22 Stifel
Inogen price target lowered to $30 from $40 at Stifel
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
KYMR Kymera Therapeutics
$28.47 /

+2.545 (+9.82%)

08/31/22 JPMorgan
Kymera selloff a 'misplaced knee-jerk reaction,' says JPMorgan
08/15/22 Jefferies
Kymera Therapeutics initiated with a Buy at Jefferies
08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
NOTV Inotiv
$20.88 /

+0.24 (+1.16%)

08/11/22 Lake Street
Inotiv price target raised to $60 from $50 at Lake Street
06/14/22 Lake Street
Inotiv price target lowered to $50 from $75 at Lake Street
02/11/22 Lake Street
Inotiv price target raised to $75 from $60 at Lake Street
02/02/22 Craig-Hallum
Inotiv price target raised to $64 from $57 at Craig-Hallum
PEN Penumbra
$186.16 /

+21.935 (+13.36%)

08/05/22 Canaccord
Penumbra price target lowered to $189 from $244 at Canaccord
07/21/22 Deutsche Bank
Penumbra price target lowered to $163 from $250 at Deutsche Bank
07/18/22 BTIG
Penumbra price target lowered to $213 from $272 at BTIG
07/18/22 RBC Capital
Penumbra initiated with an Outperform at RBC Capital
RGLS Regulus
$1.57 /

-0.01 (-0.63%)

SWAV ShockWave Medical
$286.96 /

+12.165 (+4.43%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
WAT Waters
$302.21 /

+4.705 (+1.58%)

08/24/22 Credit Suisse
Waters initiated with a Neutral at Credit Suisse
08/03/22 Baird
Waters price target raised to $348 from $340 at Baird
07/20/22 UBS
Waters initiated with a Neutral at UBS
07/05/22 Evercore ISI
Waters added to 'Tactical Outperform' list at Evercore ISI
SUPN Supernus
$34.19 /

+0.15 (+0.44%)

08/31/22 Piper Sandler
Supernus price target raised to $38 from $33 at Piper Sandler
12/01/21 Jefferies
Supernus resumed with a Buy at Jefferies
10/12/21 JMP Securities
Adamas Pharmaceuticals cut to Market Perform from Outperform at JMP Securities
10/12/21 H.C. Wainwright
Adamas Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

07/15/22 Oppenheimer
Oric Pharmaceuticals assumed with a Perform at Oppenheimer
04/04/22 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/22 H.C. Wainwright
Oric Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/22/22 Guggenheim
Oric downgraded to Neutral at Guggenheim after ORIC-101 discontinuation
PGEN Precigen
$2.31 /

+0.025 (+1.09%)

08/09/22 H.C. Wainwright
Precigen price target lowered to $6 from $10 at H.C. Wainwright
07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

07/11/22 H.C. Wainwright
Nurix Therapeutics price target lowered to $54 from $60 at H.C. Wainwright
07/08/22 Stifel
Nurix Therapeutics price target lowered to $37 from $44 at Stifel
07/08/22 JPMorgan
Nurix Therapeutics price target lowered to $37 from $46 at JPMorgan
07/08/22 Baird
Nurix Therapeutics price target lowered to $32 from $41 at Baird
NUVA NuVasive
$45.32 /

+2.34 (+5.44%)

08/23/22 Piper Sandler
NuVasive selloff on bus tour comments an opportunity, says Piper Sandler
08/04/22 Canaccord
NuVasive price target raised to $55 from $50 at Canaccord
08/04/22 Piper Sandler
NuVasive price target lowered to $60 from $80 at Piper Sandler
06/28/22 Stifel
Stifel cuts Orthofix target, says momentum 'faded' during Q2
AUTL Autolus Therapeutics
$2.94 /

-0.15 (-4.85%)

06/14/22 Truist
Autolus Therapeutics price target lowered to $11 from $13 at Truist
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
12/20/21 H.C. Wainwright
Autolus Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
HALO Halozyme
$39.39 /

+0.845 (+2.19%)

08/10/22 Benchmark
Halozyme recent weakness a buying opportunity, says Benchmark
05/23/22 SVB Securities
Halozyme initiated with an Outperform at SVB Leerink
04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
04/14/22 Raymond James
Antares Pharma downgraded to Market Perform from Strong Buy at Raymond James
IMVT Immunovant
$4.92 /

+0.03 (+0.61%)

03/30/22 Chardan
Immunovant price target lowered to $14 from $20 at Chardan
01/05/22 Chardan
Immunovant price target lowered to $20 from $22 at Chardan
12/31/21 Wells Fargo
Immunovant shares to remain range-bound in 2022, says Wells Fargo
12/08/21 Wells Fargo
Immunovant initiated with an Equal Weight at Wells Fargo
JNCE Jounce Therapeutics
$3.55 /

+0.05 (+1.43%)

08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
05/23/22 Piper Sandler
Jounce Therapeutics price target lowered to $9 from $17 at Piper Sandler
05/12/22 Roth Capital
Jounce Therapeutics recent pullback overdone, says Roth Capital
IDYA Ideaya Biosciences
$9.29 /

+0.05 (+0.54%)

08/16/22 Baird
Ideaya Biosciences price target lowered to $18 from $26 at Baird
08/16/22 Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold from Buy at Stifel
SYK Stryker
$211.20 /

+8.39 (+4.14%)

09/06/22 BTIG
Stryker price target lowered to $238 from $244 at BTIG
07/28/22 Edward Jones
Stryker upgraded to Buy at Edward Jones following pullback
07/28/22 Edward Jones
Stryker upgraded to Buy from Hold at Edward Jones
07/27/22 Wells Fargo
Stryker price target lowered to $237 from $286 at Wells Fargo
NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

04/05/22 Wolfe Research
NeuroPace initiated with an Outperform at Wolfe Research
01/19/22 Wells Fargo
Wells Fargo downgrades NeuroPace to Equal Weight, lowers price target to $11
01/19/22 Wells Fargo
NeuroPace downgraded to Equal Weight from Overweight at Wells Fargo
01/07/22 Morgan Stanley
NeuroPace cut to Underweight at Morgan Stanley on cloudy near-term outlook
IONS Ionis Pharmaceuticals
$43.43 /

+1.75 (+4.20%)

08/10/22 Citi
Ionis Pharmaceuticals price target raised to $28 from $26 at Citi
07/26/22 Piper Sandler
Ionis Pharmaceuticals price target raised to $58 from $55 at Piper Sandler
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
07/18/22 Oppenheimer
Ionis Pharmaceuticals assumed with an Outperform at Oppenheimer
HRMY Harmony Biosciences
$46.06 /

+1.7 (+3.83%)

09/01/22 Mizuho
Harmony Biosciences recent weakness a buying opportunity, says Mizuho
08/18/22 Mizuho
Harmony Biosciences Orange Book update 'incremental negative,' says Mizuho
08/03/22 Jefferies
Jefferies downgrades Harmony Biosciences to Hold, sees limited near-term upside
08/03/22 Oppenheimer
Harmony Biosciences price target raised to $67 from $62 at Oppenheimer
WAT Waters
$302.21 /

+4.705 (+1.58%)

SYK Stryker
$211.20 /

+8.39 (+4.14%)

SWAV ShockWave Medical
$286.96 /

+12.165 (+4.43%)

SUPN Supernus
$34.19 /

+0.15 (+0.44%)

RGLS Regulus
$1.57 /

-0.01 (-0.63%)

PGEN Precigen
$2.31 /

+0.025 (+1.09%)

PEN Penumbra
$186.16 /

+21.935 (+13.36%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.32 /

+2.34 (+5.44%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

LEGN Legend Biotech
$43.86 /

-0.17 (-0.39%)

KYMR Kymera Therapeutics
$28.47 /

+2.545 (+9.82%)

JNCE Jounce Therapeutics
$3.55 /

+0.05 (+1.43%)

IONS Ionis Pharmaceuticals
$43.43 /

+1.75 (+4.20%)

INSP Inspire Medical
$188.93 /

+5.92 (+3.23%)

INGN Inogen
$28.19 /

+0.6 (+2.17%)

IMVT Immunovant
$4.92 /

+0.03 (+0.61%)

IDYA Ideaya Biosciences
$9.29 /

+0.05 (+0.54%)

HRMY Harmony Biosciences
$46.06 /

+1.7 (+3.83%)

HOLX Hologic
$67.71 /

+0.33 (+0.49%)

HALO Halozyme
$39.39 /

+0.845 (+2.19%)

GILD Gilead
$64.79 /

+1.355 (+2.14%)

FATE Fate Therapeutics
$27.31 /

+2.02 (+7.99%)

DGX Quest Diagnostics
$127.38 /

+2.27 (+1.81%)

BNFT Benefitfocus
$7.04 /

+0.33 (+4.92%)

AVEO Aveo Pharmaceuticals
$8.31 /

+0.33 (+4.14%)

AUTL Autolus Therapeutics
$2.94 /

-0.15 (-4.85%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

  • 12
    Aug
  • 27
    Jul
  • 16
    Dec
SYK Stryker
$211.20 /

+8.39 (+4.14%)

GILD Gilead
$64.79 /

+1.355 (+2.14%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

SYK Stryker
$211.20 /

+8.39 (+4.14%)

SWAV ShockWave Medical
$286.96 /

+12.165 (+4.43%)

SUPN Supernus
$34.19 /

+0.15 (+0.44%)

PEN Penumbra
$186.16 /

+21.935 (+13.36%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.32 /

+2.34 (+5.44%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

LEGN Legend Biotech
$43.86 /

-0.17 (-0.39%)

KYMR Kymera Therapeutics
$28.47 /

+2.545 (+9.82%)

JNCE Jounce Therapeutics
$3.55 /

+0.05 (+1.43%)

IDYA Ideaya Biosciences
$9.29 /

+0.05 (+0.54%)

HRMY Harmony Biosciences
$46.06 /

+1.7 (+3.83%)

HOLX Hologic
$67.71 /

+0.33 (+0.49%)

HALO Halozyme
$39.39 /

+0.845 (+2.19%)

GILD Gilead
$64.79 /

+1.355 (+2.14%)

FATE Fate Therapeutics
$27.31 /

+2.02 (+7.99%)

DGX Quest Diagnostics
$127.38 /

+2.27 (+1.81%)

AVEO Aveo Pharmaceuticals
$8.31 /

+0.33 (+4.14%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

WAT Waters
$302.21 /

+4.705 (+1.58%)

SYK Stryker
$211.20 /

+8.39 (+4.14%)

GILD Gilead
$64.79 /

+1.355 (+2.14%)

ABBV AbbVie
$139.04 /

+1.4 (+1.02%)

Conference/Events
Wells Fargo to hold a conference » 16:08
09/07/22
09/07
16:08
09/07/22
16:08
ABBV

AbbVie

$138.72 /

+1.08 (+0.78%)

, AVEO

Aveo Pharmaceuticals

$8.35 /

+0.37 (+4.64%)

, BNFT

Benefitfocus

$7.02 /

+0.31 (+4.62%)

, DGX

Quest Diagnostics

$127.43 /

+2.325 (+1.86%)

, FATE

Fate Therapeutics

$27.32 /

+2.03 (+8.03%)

, INSP

Inspire Medical

$188.51 /

+5.5 (+3.01%)

, LEGN

Legend Biotech

$43.82 /

-0.21 (-0.48%)

, GILD

Gilead

$64.88 /

+1.45 (+2.29%)

, HOLX

Hologic

$67.72 /

+0.34 (+0.50%)

, INGN

Inogen

$28.45 /

+0.86 (+3.12%)

, KYMR

Kymera Therapeutics

$28.48 /

+2.555 (+9.86%)

, NOTV

Inotiv

$21.03 /

+0.39 (+1.89%)

, PEN

Penumbra

$184.98 /

+20.76 (+12.64%)

, RGLS

Regulus

$1.54 /

-0.04 (-2.53%)

, SWAV

ShockWave Medical

$287.16 /

+12.37 (+4.50%)

, WAT

Waters

$302.39 /

+4.89 (+1.64%)

, SUPN

Supernus

$34.11 /

+0.07 (+0.21%)

, ORIC

Oric Pharmaceuticals

$3.46 /

-0.09 (-2.54%)

, PGEN

Precigen

$2.31 /

+0.02 (+0.88%)

, NRIX

Nurix Therapeutics

$16.12 /

+0.83 (+5.43%)

, NUVA

NuVasive

$45.25 /

+2.27 (+5.28%)

, AUTL

Autolus Therapeutics

$2.93 /

-0.16 (-5.18%)

, HALO

Halozyme

$39.40 /

+0.855 (+2.22%)

, IMVT

Immunovant

$4.95 /

+0.06 (+1.23%)

, JNCE

Jounce Therapeutics

$3.61 /

+0.11 (+3.14%)

, IDYA

Ideaya Biosciences

$9.25 /

+0.01 (+0.11%)

, SYK

Stryker

$210.95 /

+8.14 (+4.01%)

, NPCE

NeuroPace

$4.73 /

+0.01 (+0.21%)

, IONS

Ionis Pharmaceuticals

$43.27 /

+1.585 (+3.80%)

, HRMY

Harmony Biosciences

$45.98 /

+1.62 (+3.65%)

2022 Wells Fargo…

2022 Wells Fargo Healthcare Conference to be held in Everett, MA on September 7-9.

ShowHide Related Items >><<
SYK Stryker
$210.95 /

+8.14 (+4.01%)

SWAV ShockWave Medical
$287.16 /

+12.37 (+4.50%)

SUPN Supernus
$34.11 /

+0.07 (+0.21%)

RGLS Regulus
$1.54 /

-0.04 (-2.53%)

PGEN Precigen
$2.31 /

+0.02 (+0.88%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.25 /

+2.27 (+5.28%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

NOTV Inotiv
$21.03 /

+0.39 (+1.89%)

LEGN Legend Biotech
$43.82 /

-0.21 (-0.48%)

KYMR Kymera Therapeutics
$28.48 /

+2.555 (+9.86%)

JNCE Jounce Therapeutics
$3.61 /

+0.11 (+3.14%)

IONS Ionis Pharmaceuticals
$43.27 /

+1.585 (+3.80%)

INSP Inspire Medical
$188.51 /

+5.5 (+3.01%)

IMVT Immunovant
$4.95 /

+0.06 (+1.23%)

IDYA Ideaya Biosciences
$9.25 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$45.98 /

+1.62 (+3.65%)

HOLX Hologic
$67.72 /

+0.34 (+0.50%)

HALO Halozyme
$39.40 /

+0.855 (+2.22%)

GILD Gilead
$64.88 /

+1.45 (+2.29%)

FATE Fate Therapeutics
$27.32 /

+2.03 (+8.03%)

DGX Quest Diagnostics
$127.43 /

+2.325 (+1.86%)

BNFT Benefitfocus
$7.02 /

+0.31 (+4.62%)

AVEO Aveo Pharmaceuticals
$8.35 /

+0.37 (+4.64%)

AUTL Autolus Therapeutics
$2.93 /

-0.16 (-5.18%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

08/30/22 Piper Sandler
I-Mab price target lowered to $30 from $35 at Piper Sandler
08/24/22 Argus
AbbVie price target lowered to $155 from $165 at Argus
08/01/22 JPMorgan
AbbVie selloff Friday a buying opportunity, says JPMorgan
08/01/22 Barclays
AbbVie price target lowered to $160 from $174 at Barclays
AVEO Aveo Pharmaceuticals
$8.35 /

+0.37 (+4.64%)

03/14/22 JonesTrading
Aveo Pharmaceuticals initiated with a Buy at JonesTrading
BNFT Benefitfocus
$7.02 /

+0.31 (+4.62%)

09/06/22 Piper Sandler
Benefitfocus price target lowered to $6 from $9 at Piper Sandler
06/22/22 Piper Sandler
Benefitfocus downgraded to Neutral from Overweight at Piper Sandler
DGX Quest Diagnostics
$127.43 /

+2.325 (+1.86%)

08/22/22 Morgan Stanley
Quest Diagnostics assumed with an Equal Weight at Morgan Stanley
07/22/22 Mizuho
Quest Diagnostics price target lowered to $160 from $185 at Mizuho
07/22/22 Credit Suisse
Quest Diagnostics price target lowered to $143 from $158 at Credit Suisse
04/24/22 UBS
Quest Diagnostics price target raised to $150 from $139 at UBS
FATE Fate Therapeutics
$27.32 /

+2.03 (+8.03%)

08/18/22 Wells Fargo
Fate Therapeutics assumed with an Overweight at Wells Fargo
08/04/22 Oppenheimer
Fate Therapeutics price target lowered to $90 from $135 at Oppenheimer
07/28/22 Needham
Fate Therapeutics initiated with a Hold at Needham
07/11/22 BMO Capital
Fate Therapeutics upgraded to Outperform from Market Perform at BMO Capital
INSP Inspire Medical
$188.51 /

+5.5 (+3.01%)

08/03/22 Truist
Inspire Medical price target raised to $280 from $250 at Truist
08/03/22 Piper Sandler
Inspire Medical price target lowered to $285 from $310 at Piper Sandler
07/05/22 Piper Sandler
Piper says Inspire appears to have received FDA approval for expanded labeling
06/10/22 Truist
Inspire Medical price target lowered to $250 from $296 at Truist
LEGN Legend Biotech
$43.82 /

-0.21 (-0.48%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/16/22 BMO Capital
Legend Biotech initiated with an Outperform at BMO Capital
05/31/22 Morgan Stanley
Legend Biotech named Catalyst Driven Idea by Morgan Stanley
03/15/22 Barclays
Legend Biotech initiated with an Overweight at Barclays
GILD Gilead
$64.88 /

+1.45 (+2.29%)

09/02/22 Argus
Gilead pullback provides favorable entry point, says Argus
08/15/22 Piper Sandler
Gilead's Trodelvy shows OS benefit in HR+/HER- BC, says Piper Sandler
08/15/22 Piper Sandler
Gilead price target raised to $74 from $71 at Piper Sandler
08/08/22 Truist
Gilead price target lowered to $71 from $75 at Truist
HOLX Hologic
$67.72 /

+0.34 (+0.50%)

07/22/22 Evercore ISI
Intuitive Surgical price target lowered to $175 from $210 at Evercore ISI
07/20/22 UBS
Hologic initiated with a Neutral at UBS
07/20/22 BofA
BofA cuts Hologic to Neutral amid difficult macro, ongoing supply chain issues
07/20/22 BofA
Hologic downgraded to Neutral from Buy at BofA
INGN Inogen
$28.45 /

+0.86 (+3.12%)

05/09/22 Stifel
Inogen price target lowered to $30 from $40 at Stifel
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
KYMR Kymera Therapeutics
$28.48 /

+2.555 (+9.86%)

08/31/22 JPMorgan
Kymera selloff a 'misplaced knee-jerk reaction,' says JPMorgan
08/15/22 Jefferies
Kymera Therapeutics initiated with a Buy at Jefferies
08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
NOTV Inotiv
$21.03 /

+0.39 (+1.89%)

08/11/22 Lake Street
Inotiv price target raised to $60 from $50 at Lake Street
06/14/22 Lake Street
Inotiv price target lowered to $50 from $75 at Lake Street
02/11/22 Lake Street
Inotiv price target raised to $75 from $60 at Lake Street
02/02/22 Craig-Hallum
Inotiv price target raised to $64 from $57 at Craig-Hallum
PEN Penumbra
$184.98 /

+20.76 (+12.64%)

08/05/22 Canaccord
Penumbra price target lowered to $189 from $244 at Canaccord
07/21/22 Deutsche Bank
Penumbra price target lowered to $163 from $250 at Deutsche Bank
07/18/22 BTIG
Penumbra price target lowered to $213 from $272 at BTIG
07/18/22 RBC Capital
Penumbra initiated with an Outperform at RBC Capital
RGLS Regulus
$1.54 /

-0.04 (-2.53%)

SWAV ShockWave Medical
$287.16 /

+12.37 (+4.50%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
WAT Waters
$302.39 /

+4.89 (+1.64%)

08/24/22 Credit Suisse
Waters initiated with a Neutral at Credit Suisse
08/03/22 Baird
Waters price target raised to $348 from $340 at Baird
07/20/22 UBS
Waters initiated with a Neutral at UBS
07/05/22 Evercore ISI
Waters added to 'Tactical Outperform' list at Evercore ISI
SUPN Supernus
$34.11 /

+0.07 (+0.21%)

08/31/22 Piper Sandler
Supernus price target raised to $38 from $33 at Piper Sandler
12/01/21 Jefferies
Supernus resumed with a Buy at Jefferies
10/12/21 JMP Securities
Adamas Pharmaceuticals cut to Market Perform from Outperform at JMP Securities
10/12/21 H.C. Wainwright
Adamas Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

07/15/22 Oppenheimer
Oric Pharmaceuticals assumed with a Perform at Oppenheimer
04/04/22 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/22 H.C. Wainwright
Oric Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/22/22 Guggenheim
Oric downgraded to Neutral at Guggenheim after ORIC-101 discontinuation
PGEN Precigen
$2.31 /

+0.02 (+0.88%)

08/09/22 H.C. Wainwright
Precigen price target lowered to $6 from $10 at H.C. Wainwright
07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

07/11/22 H.C. Wainwright
Nurix Therapeutics price target lowered to $54 from $60 at H.C. Wainwright
07/08/22 Stifel
Nurix Therapeutics price target lowered to $37 from $44 at Stifel
07/08/22 JPMorgan
Nurix Therapeutics price target lowered to $37 from $46 at JPMorgan
07/08/22 Baird
Nurix Therapeutics price target lowered to $32 from $41 at Baird
NUVA NuVasive
$45.25 /

+2.27 (+5.28%)

08/23/22 Piper Sandler
NuVasive selloff on bus tour comments an opportunity, says Piper Sandler
08/04/22 Canaccord
NuVasive price target raised to $55 from $50 at Canaccord
08/04/22 Piper Sandler
NuVasive price target lowered to $60 from $80 at Piper Sandler
06/28/22 Stifel
Stifel cuts Orthofix target, says momentum 'faded' during Q2
AUTL Autolus Therapeutics
$2.93 /

-0.16 (-5.18%)

06/14/22 Truist
Autolus Therapeutics price target lowered to $11 from $13 at Truist
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
12/20/21 H.C. Wainwright
Autolus Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
HALO Halozyme
$39.40 /

+0.855 (+2.22%)

08/10/22 Benchmark
Halozyme recent weakness a buying opportunity, says Benchmark
05/23/22 SVB Securities
Halozyme initiated with an Outperform at SVB Leerink
04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
04/14/22 Raymond James
Antares Pharma downgraded to Market Perform from Strong Buy at Raymond James
IMVT Immunovant
$4.95 /

+0.06 (+1.23%)

03/30/22 Chardan
Immunovant price target lowered to $14 from $20 at Chardan
01/05/22 Chardan
Immunovant price target lowered to $20 from $22 at Chardan
12/31/21 Wells Fargo
Immunovant shares to remain range-bound in 2022, says Wells Fargo
12/08/21 Wells Fargo
Immunovant initiated with an Equal Weight at Wells Fargo
JNCE Jounce Therapeutics
$3.61 /

+0.11 (+3.14%)

08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
05/23/22 Piper Sandler
Jounce Therapeutics price target lowered to $9 from $17 at Piper Sandler
05/12/22 Roth Capital
Jounce Therapeutics recent pullback overdone, says Roth Capital
IDYA Ideaya Biosciences
$9.25 /

+0.01 (+0.11%)

08/16/22 Baird
Ideaya Biosciences price target lowered to $18 from $26 at Baird
08/16/22 Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold from Buy at Stifel
SYK Stryker
$210.95 /

+8.14 (+4.01%)

09/06/22 BTIG
Stryker price target lowered to $238 from $244 at BTIG
07/28/22 Edward Jones
Stryker upgraded to Buy at Edward Jones following pullback
07/28/22 Edward Jones
Stryker upgraded to Buy from Hold at Edward Jones
07/27/22 Wells Fargo
Stryker price target lowered to $237 from $286 at Wells Fargo
NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

04/05/22 Wolfe Research
NeuroPace initiated with an Outperform at Wolfe Research
01/19/22 Wells Fargo
Wells Fargo downgrades NeuroPace to Equal Weight, lowers price target to $11
01/19/22 Wells Fargo
NeuroPace downgraded to Equal Weight from Overweight at Wells Fargo
01/07/22 Morgan Stanley
NeuroPace cut to Underweight at Morgan Stanley on cloudy near-term outlook
IONS Ionis Pharmaceuticals
$43.27 /

+1.585 (+3.80%)

08/10/22 Citi
Ionis Pharmaceuticals price target raised to $28 from $26 at Citi
07/26/22 Piper Sandler
Ionis Pharmaceuticals price target raised to $58 from $55 at Piper Sandler
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
07/18/22 Oppenheimer
Ionis Pharmaceuticals assumed with an Outperform at Oppenheimer
HRMY Harmony Biosciences
$45.98 /

+1.62 (+3.65%)

09/01/22 Mizuho
Harmony Biosciences recent weakness a buying opportunity, says Mizuho
08/18/22 Mizuho
Harmony Biosciences Orange Book update 'incremental negative,' says Mizuho
08/03/22 Jefferies
Jefferies downgrades Harmony Biosciences to Hold, sees limited near-term upside
08/03/22 Oppenheimer
Harmony Biosciences price target raised to $67 from $62 at Oppenheimer
WAT Waters
$302.39 /

+4.89 (+1.64%)

SYK Stryker
$210.95 /

+8.14 (+4.01%)

SWAV ShockWave Medical
$287.16 /

+12.37 (+4.50%)

SUPN Supernus
$34.11 /

+0.07 (+0.21%)

RGLS Regulus
$1.54 /

-0.04 (-2.53%)

PGEN Precigen
$2.31 /

+0.02 (+0.88%)

PEN Penumbra
$184.98 /

+20.76 (+12.64%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.25 /

+2.27 (+5.28%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

NPCE NeuroPace
$4.73 /

+0.01 (+0.21%)

LEGN Legend Biotech
$43.82 /

-0.21 (-0.48%)

KYMR Kymera Therapeutics
$28.48 /

+2.555 (+9.86%)

JNCE Jounce Therapeutics
$3.61 /

+0.11 (+3.14%)

IONS Ionis Pharmaceuticals
$43.27 /

+1.585 (+3.80%)

INSP Inspire Medical
$188.51 /

+5.5 (+3.01%)

INGN Inogen
$28.45 /

+0.86 (+3.12%)

IMVT Immunovant
$4.95 /

+0.06 (+1.23%)

IDYA Ideaya Biosciences
$9.25 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$45.98 /

+1.62 (+3.65%)

HOLX Hologic
$67.72 /

+0.34 (+0.50%)

HALO Halozyme
$39.40 /

+0.855 (+2.22%)

GILD Gilead
$64.88 /

+1.45 (+2.29%)

FATE Fate Therapeutics
$27.32 /

+2.03 (+8.03%)

DGX Quest Diagnostics
$127.43 /

+2.325 (+1.86%)

BNFT Benefitfocus
$7.02 /

+0.31 (+4.62%)

AVEO Aveo Pharmaceuticals
$8.35 /

+0.37 (+4.64%)

AUTL Autolus Therapeutics
$2.93 /

-0.16 (-5.18%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

  • 12
    Aug
  • 27
    Jul
  • 16
    Dec
SYK Stryker
$210.95 /

+8.14 (+4.01%)

GILD Gilead
$64.88 /

+1.45 (+2.29%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

SYK Stryker
$210.95 /

+8.14 (+4.01%)

SWAV ShockWave Medical
$287.16 /

+12.37 (+4.50%)

SUPN Supernus
$34.11 /

+0.07 (+0.21%)

PEN Penumbra
$184.98 /

+20.76 (+12.64%)

ORIC Oric Pharmaceuticals
$3.46 /

-0.09 (-2.54%)

NUVA NuVasive
$45.25 /

+2.27 (+5.28%)

NRIX Nurix Therapeutics
$16.12 /

+0.83 (+5.43%)

LEGN Legend Biotech
$43.82 /

-0.21 (-0.48%)

KYMR Kymera Therapeutics
$28.48 /

+2.555 (+9.86%)

JNCE Jounce Therapeutics
$3.61 /

+0.11 (+3.14%)

IDYA Ideaya Biosciences
$9.25 /

+0.01 (+0.11%)

HRMY Harmony Biosciences
$45.98 /

+1.62 (+3.65%)

HOLX Hologic
$67.72 /

+0.34 (+0.50%)

HALO Halozyme
$39.40 /

+0.855 (+2.22%)

GILD Gilead
$64.88 /

+1.45 (+2.29%)

FATE Fate Therapeutics
$27.32 /

+2.03 (+8.03%)

DGX Quest Diagnostics
$127.43 /

+2.325 (+1.86%)

AVEO Aveo Pharmaceuticals
$8.35 /

+0.37 (+4.64%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

WAT Waters
$302.39 /

+4.89 (+1.64%)

SYK Stryker
$210.95 /

+8.14 (+4.01%)

GILD Gilead
$64.88 /

+1.45 (+2.29%)

ABBV AbbVie
$138.72 /

+1.08 (+0.78%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:00
09/06/22
09/06
10:00
09/06/22
10:00
TSLA

Tesla

$271.53 /

+1.33 (+0.49%)

, NXST

Nexstar

$190.63 /

-0.03 (-0.02%)

, NEE

NextEra Energy

$87.85 /

+2.735 (+3.21%)

, PRGO

Perrigo

$37.46 /

+0.745 (+2.03%)

, MTD

Mettler-Toledo

$1,219.50 /

+22.16 (+1.85%)

, FDX

FedEx

$204.80 /

-3.68 (-1.77%)

, GS

Goldman Sachs

$329.62 /

-1.18 (-0.36%)

, MS

Morgan Stanley

$85.22 /

-1.185 (-1.37%)

, CS

Credit Suisse

$5.10 /

-0.015 (-0.29%)

, DFS

Discover

$97.64 /

-1.76 (-1.77%)

, SWAV

ShockWave Medical

$272.58 /

-19.69 (-6.74%)

, CG

Carlyle Group

$32.13 /

-0.12 (-0.37%)

, LYFT

Lyft

$14.37 /

-0.24 (-1.64%)

, UBER

Uber

$29.02 /

-0.02 (-0.07%)

, LITE

Lumentum

$79.42 /

-0.11 (-0.14%)

, WLK

Westlake

$97.69 /

+2.14 (+2.24%)

, OLN

Olin

$53.64 /

+0.32 (+0.60%)

, DBX

Dropbox

$22.02 /

+0.875 (+4.14%)

Institutional investors…

ShowHide Related Items >><<
WLK Westlake
$97.69 /

+2.14 (+2.24%)

UBER Uber
$29.02 /

-0.02 (-0.07%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

SWAV ShockWave Medical
$272.58 /

-19.69 (-6.74%)

PRGO Perrigo
$37.46 /

+0.745 (+2.03%)

OLN Olin
$53.64 /

+0.32 (+0.60%)

NXST Nexstar
$190.63 /

-0.03 (-0.02%)

NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

MTD Mettler-Toledo
$1,219.50 /

+22.16 (+1.85%)

MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

LYFT Lyft
$14.37 /

-0.24 (-1.64%)

LITE Lumentum
$79.42 /

-0.11 (-0.14%)

GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

FDX FedEx
$204.80 /

-3.68 (-1.77%)

DFS Discover
$97.64 /

-1.76 (-1.77%)

DBX Dropbox
$22.02 /

+0.875 (+4.14%)

CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

CG Carlyle Group
$32.13 /

-0.12 (-0.37%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

09/06/22 Wolfe Research
Wolfe upgrades Tesla to Outperform on underappreciated IRA benefits
09/06/22 Wolfe Research
Tesla upgraded to Outperform from Peer Perform at Wolfe Research
09/01/22 Piper Sandler
Piper boosts Tesla target but shares may selloff in coming weeks
08/29/22 Deutsche Bank
Tesla Gigafactory in Berlin 'could be a game-changer,' says Deutsche Bank
NXST Nexstar
$190.63 /

-0.03 (-0.02%)

09/06/22 Rosenblatt
Nexstar upgraded to Buy from Neutral at Rosenblatt
08/15/22 Benchmark
Nexstar getting 75% stake in CW Network for 'free,' says Benchmark
08/08/22 Barrington
Nexstar price target raised to $240 from $215 at Barrington
05/12/22 Deutsche Bank
Nexstar price target raised to $225 from $216 at Deutsche Bank
NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

09/06/22 Morgan Stanley
NextEra Energy assumed at Overweight from Equal Weight at Morgan Stanley
08/18/22 Morgan Stanley
NextEra Energy price target raised to $94 from $83 at Morgan Stanley
07/26/22 Seaport Global
NextEra Energy downgraded to Neutral from Buy at Seaport Global
07/18/22 Barclays
NextEra Energy price target lowered to $86 from $90 at Barclays
PRGO Perrigo
$37.46 /

+0.745 (+2.03%)

09/06/22 Wells Fargo
Wells Fargo upgrades Perrigo to Overweight, raises price target to $54
09/06/22 Wells Fargo
Perrigo upgraded to Overweight from Equal Weight at Wells Fargo
08/18/22 JPMorgan
Generic manufacturer selloff yesterday 'very much overdone,' says JPMorgan
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
MTD Mettler-Toledo
$1,219.50 /

+22.16 (+1.85%)

09/06/22 Stifel
Mettler-Toledo upgraded to Buy at Stifel after 30% year-to-date pullback
09/06/22 Stifel
Mettler-Toledo upgraded to Buy from Hold at Stifel
08/01/22 Baird
Mettler-Toledo price target raised to $1406 from $1369 at Baird
07/20/22 UBS
Mettler-Toledo initiated with a Neutral at UBS
FDX FedEx
$204.80 /

-3.68 (-1.77%)

09/06/22 Citi
Citi opens 'negative catalyst watch' on Norfolk Southern
09/06/22 Citi
FedEx downgraded to Neutral from Buy at Citi
08/25/22 BMO Capital
FedEx price target lowered to $270 from $280 at BMO Capital
08/22/22 Evercore ISI
FedEx added to Tactical Underperform list at Evercore ISI
GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

09/06/22 Odeon Capital
Goldman Sachs downgraded to Sell from Hold at Odeon Capital
07/19/22 BMO Capital
Goldman Sachs price target lowered to $461 from $475 at BMO Capital
07/19/22 Barclays
Goldman Sachs price target lowered to $450 from $505 at Barclays
07/12/22 Citi
Goldman Sachs price target lowered to $360 from $400 at Citi
MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

09/06/22 Odeon Capital
Morgan Stanley downgraded to Sell from Hold at Odeon Capital
07/15/22 Oppenheimer
Morgan Stanley price target lowered to $93 from $97 at Oppenheimer
07/15/22 BMO Capital
Morgan Stanley price target lowered to $99 from $105 at BMO Capital
07/15/22 Barclays
Morgan Stanley price target lowered to $108 from $123 at Barclays
CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

08/31/22 Deutsche Bank
Credit Suisse price target lowered to CHF 6 from CHF 7 at Deutsche Bank
08/03/22 Berenberg
Credit Suisse price target lowered to CHF 7 from CHF 8 at Berenberg
08/02/22 Goldman Sachs
Credit Suisse downgraded to Sell from Neutral at Goldman Sachs
07/28/22 Barclays
Credit Suisse price target lowered to CHF 4 from CHF 5 at Barclays
DFS Discover
$97.64 /

-1.76 (-1.77%)

09/06/22 JPMorgan
Discover downgraded on more cautious consumer outlook at JPMorgan
09/06/22 JPMorgan
Discover downgraded to Neutral from Overweight at JPMorgan
07/25/22 BMO Capital
Discover price target lowered to $118 from $131 at BMO Capital
07/24/22 BofA
Discover price target lowered to $120 from $128 at BofA
SWAV ShockWave Medical
$272.58 /

-19.69 (-6.74%)

09/06/22 Oppenheimer
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target
09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
CG Carlyle Group
$32.13 /

-0.12 (-0.37%)

09/06/22 BofA
BofA double downgrades Carlyle to Underperform on slowing growth
09/06/22 BofA
Carlyle Group downgraded to Underperform from Buy at BofA
08/12/22 Deutsche Bank
Carlyle Group price target lowered to $43 from $56 at Deutsche Bank
08/09/22 Jefferies
Carlyle Group downgraded to Hold from Buy at Jefferies
LYFT Lyft
$14.37 /

-0.24 (-1.64%)

09/06/22 BofA
BofA starts Lyft at Underperform with $14 price target
09/06/22 BofA
Lyft initiated with an Underperform at BofA
08/15/22 Guggenheim
Lyft price target lowered to $28 from $32 at Guggenheim
08/12/22 Tigress Financial
Lyft price target lowered to $60 from $82 at Tigress Financial
UBER Uber
$29.02 /

-0.02 (-0.07%)

08/23/22 Wolfe Research
Uber remains top idea in mobility at Wolfe Research
08/05/22 Wedbush
Uber's June quarter a step in the right direction, says Wedbush
08/03/22 MKM Partners
Uber price target raised to $40 from $32 at MKM Partners
LITE Lumentum
$79.42 /

-0.11 (-0.14%)

09/06/22 BofA
BofA starts Lumentum at Buy on attractive valuation, improving product mix
09/06/22 BofA
Lumentum initiated with a Buy at BofA
09/02/22 Northland
Ciena price target lowered to $45 from $53 at Northland
08/17/22 Raymond James
Lumentum price target raised to $114 from $102 at Raymond James
WLK Westlake
$97.69 /

+2.14 (+2.24%)

09/06/22 Credit Suisse
Westlake initiated with an Outperform at Credit Suisse
08/29/22 KeyBanc
KeyBanc downgrades chemical stocks into 'recession' level earnings
08/29/22 KeyBanc
Westlake downgraded to Underweight from Sector Weight at KeyBanc
08/17/22 JPMorgan
JPMorgan upgrades Westlake to Overweight, sees room for multiple to rise
OLN Olin
$53.64 /

+0.32 (+0.60%)

09/06/22 Credit Suisse
Olin initiated with an Underperform at Credit Suisse
08/02/22 Piper Sandler
Olin price target lowered to $73 from $80 at Piper Sandler
08/01/22 Wells Fargo
Olin price target lowered to $69 from $78 at Wells Fargo
DBX Dropbox
$22.02 /

+0.875 (+4.14%)

09/06/22 BofA
BofA starts Dropbox at Buy, sees 'strong monetization engine'
09/06/22 BofA
Dropbox initiated with a Buy at BofA
09/01/22 Citi
Dropbox initiated with a Neutral at Citi
05/23/22 Jefferies
Dropbox price target lowered to $30 from $35 at Jefferies
WLK Westlake
$97.69 /

+2.14 (+2.24%)

UBER Uber
$29.02 /

-0.02 (-0.07%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

SWAV ShockWave Medical
$272.58 /

-19.69 (-6.74%)

PRGO Perrigo
$37.46 /

+0.745 (+2.03%)

OLN Olin
$53.64 /

+0.32 (+0.60%)

NXST Nexstar
$190.63 /

-0.03 (-0.02%)

NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

MTD Mettler-Toledo
$1,219.50 /

+22.16 (+1.85%)

MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

LYFT Lyft
$14.37 /

-0.24 (-1.64%)

LITE Lumentum
$79.42 /

-0.11 (-0.14%)

GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

FDX FedEx
$204.80 /

-3.68 (-1.77%)

DFS Discover
$97.64 /

-1.76 (-1.77%)

DBX Dropbox
$22.02 /

+0.875 (+4.14%)

CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

CG Carlyle Group
$32.13 /

-0.12 (-0.37%)

  • 10
    Nov
UBER Uber
$29.02 /

-0.02 (-0.07%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

PRGO Perrigo
$37.46 /

+0.745 (+2.03%)

NXST Nexstar
$190.63 /

-0.03 (-0.02%)

NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

LYFT Lyft
$14.37 /

-0.24 (-1.64%)

GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

FDX FedEx
$204.80 /

-3.68 (-1.77%)

DFS Discover
$97.64 /

-1.76 (-1.77%)

DBX Dropbox
$22.02 /

+0.875 (+4.14%)

CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

CG Carlyle Group
$32.13 /

-0.12 (-0.37%)

WLK Westlake
$97.69 /

+2.14 (+2.24%)

UBER Uber
$29.02 /

-0.02 (-0.07%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

SWAV ShockWave Medical
$272.58 /

-19.69 (-6.74%)

OLN Olin
$53.64 /

+0.32 (+0.60%)

NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

MTD Mettler-Toledo
$1,219.50 /

+22.16 (+1.85%)

MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

LYFT Lyft
$14.37 /

-0.24 (-1.64%)

LITE Lumentum
$79.42 /

-0.11 (-0.14%)

GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

FDX FedEx
$204.80 /

-3.68 (-1.77%)

DFS Discover
$97.64 /

-1.76 (-1.77%)

DBX Dropbox
$22.02 /

+0.875 (+4.14%)

CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

CG Carlyle Group
$32.13 /

-0.12 (-0.37%)

UBER Uber
$29.02 /

-0.02 (-0.07%)

TSLA Tesla
$271.53 /

+1.33 (+0.49%)

NEE NextEra Energy
$87.85 /

+2.735 (+3.21%)

MS Morgan Stanley
$85.22 /

-1.185 (-1.37%)

LYFT Lyft
$14.37 /

-0.24 (-1.64%)

GS Goldman Sachs
$329.62 /

-1.18 (-0.36%)

FDX FedEx
$204.80 /

-3.68 (-1.77%)

DFS Discover
$97.64 /

-1.76 (-1.77%)

DBX Dropbox
$22.02 /

+0.875 (+4.14%)

CS Credit Suisse
$5.10 /

-0.015 (-0.29%)

Downgrade
Oppenheimer downgrades ShockWave Medical to Underperform with $165 price target » 07:42
09/06/22
09/06
07:42
09/06/22
07:42
SWAV

ShockWave Medical

$292.19 /

-4.09 (-1.38%)

As previously reported,…

As previously reported, Oppenheimer analyst Suraj Kalia downgraded ShockWave Medical to Underperform from Perform with a $165 price target. The analyst argues that clinical evidence on SWAV IVL was mixed, at best, TAM is nowhere close to implied Street outlook, and high ASP is unsustainable. Further, Kalia also cites lack of IP protection, which results in low barriers to entry, and says quarterly outperformance "cannot keep up with expectations," therefore limiting material stock upside.

ShowHide Related Items >><<
SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

09/06/22 Oppenheimer
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer
08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
08/09/22 Morgan Stanley
ShockWave Medical price target raised to $255 from $201 at Morgan Stanley
SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

Downgrade
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer » 06:25
09/06/22
09/06
06:25
09/06/22
06:25
SWAV

ShockWave Medical

$292.19 /

-4.09 (-1.38%)

Oppenheimer analyst Suraj…

Oppenheimer analyst Suraj Kalia downgraded ShockWave Medical to Underperform from Perform with a $165 price target.

ShowHide Related Items >><<
SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

08/29/22 Piper Sandler
ShockWave Medical price target raised to $338 from $278 at Piper Sandler
08/09/22 Canaccord
ShockWave Medical price target raised to $256 from $232 at Canaccord
08/09/22 Morgan Stanley
ShockWave Medical price target raised to $255 from $201 at Morgan Stanley
08/09/22 Wells Fargo
ShockWave Medical price target raised to $255 from $176 at Wells Fargo
SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

SWAV ShockWave Medical
$292.19 /

-4.09 (-1.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.